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Humans generate 2.4 million red blood cells every second, a highly dynamic 
process that consists of several developmental stages regulated by multiple 
hormones. The earliest committed progenitor, the burst-forming unit erythroid 
(BFU-E), responds to multiple hormones including Erythropoietin (EPO), a 
principal regulator of red blood cell production. As BFU-Es divide they can 
generate additional BFU-Es through partial self-renewal, as well as later EPO- 
dependent colony-forming unit erythroid (CFU-E) progenitors. EPO binds to EPO 
receptors on the surface of committed erythroid CFU-E progenitors, blocking 
apoptosis and triggering terminal erythroid differentiation
1-3
.  
While CFU-E erythroid progenitors are mainly controlled by EPO, the regulation 
of earlier BFU-E progenitors by a more expansive set of hormones, including 
glucocorticoids, which stimulate BFU-E self-renewal under stress conditions, is 
less understood
2
. Furthermore, compared to our understanding of 
protein-mediated mechanisms controlling the differentiation of CFU-Es to mature 
erythrocytes, far less is known about how microRNAs are involved in the 
regulation of this process
4,5
. 
To elucidate the mechanisms underlying BFU-E self-renewal, I identified the 
RNA binding protein Zfp36l2 as a transcriptional target of the glucocorticoid 
receptor (GR) in BFU-Es
6
. I found that Zfp36l2 is normally downregulated during 
erythroid differentiation from the BFU-E stage but its expression is maintained by 




Zfp36l2 is required for BFU-E self-renewal, as knockdown of Zfp36l2 disrupted 
glucocorticoid-induced BFU-E self-renewal in cultured BFU-E cells, and 
prevented expansion of erythroid lineage progenitors normally seen following 
induction of anemia by phenylhydrazine treatment in transplanted erythroid 
progenitors. Mechanistically, Zfp36l2 preferentially binds to mRNAs that are 
induced or maintained at high expression levels during erythroid differentiation 
and negatively regulates their expression levels. Thus, my research showed that 




To better understand the role microRNAs play in terminal erythropoiesis, I found 
using RNA-seq technology, that the majority of microRNAs present in CFU-E 
erythroid progenitors are downregulated during terminal erythroid differentiation
7
. 
Of the developmentally downregulated microRNAs, ectopic overexpression of 
miR-191 blocked erythroid enucleation but had minor effects on proliferation and 
differentiation. I identified mRNAs encoded by two erythroid enriched and 
developmentally upregulated genes, Riok3 and Mxi1, as direct targets of miR-191. 
Knockdown of either RIOK3 or MXI1 blocked enucleation and either 
physiological overexpression of miR-191 or knockdown of RIOK3 or MXI1 
blocked chromatin condensation. Thus my work established that downregulation 
of miR-191 is essential for erythroid chromatin condensation and enucleation by 
allowing upregulation of RIOK3 and MXI1
7
. 
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5. Introduction  
5.1 Development and stem cells 
The formation of the human body is a complex developmental process. Enormous 
numbers of cellular and molecular events occur both spatially and temporally as a 
single-celled fertilized egg divides and develops into a multicellular organism. This 
fertilized egg, the first cell of the organism, is pluripotent and is capable of generating 
the whole organism: the egg first undergoes cleavage, which leads to the formation of 
the blastula, followed by the gastrula and neurula, and finally, the adult body. 
During the first few cleavages and the formation of the blastula, the division and 
differentiation of the pluripotent fertilized egg forms the basis of three germ layers, 
the endoderm, the mesoderm and the ectoderm. As one of the best studied model 
organisms for early embryonic development, the frog Xenopus has helped us 
understand how the interaction of multiple signaling pathways, such as Nodal, BMP, 
and Wnt pathways, controls the formation of these three germ layers. During the later 
developmental stage of gastrulation, the pre- patterned cells of the three germ layers 
undergo extensive cell movements leading to the formation of the basic body pattern 
along the anterior-posterior axis and dorsal-ventral axis. Further development, 
including neurulation and organogenesis, leads to the formation of an adult organism 
with multiple organs and systems (Figure 1)
1
. 
The blood-forming system is one of these critical systems (Figure 2)
2,3
. The earliest 
hematopoietic organ is the yolk sac, where the hemangioblast generates both  
  8 
 
Figure 1. Xenopus embryogenesis is a multistage developmental process. The 
fertilized egg undergoes cleavage, gastrulation, neurulation, and organogenesis, 
leading to the formation of the adult organism
1
. 
endothelial cells and primitive, or embryonic, red blood cells, which are large and 
express mainly embryonic hemoglobins
4,5
. This early hematopoiesis is called 
primitive hematopoiesis since it generates primitive erythrocytes. During later 
embryonic development, hematopoiesis moves to the AGM region (aorta, gonad, 
mesonephros region) and the placenta, where hemogenic endothelial cells are capable 
of generating both hematopoietic stem cells and endothelial cells. In contrast to early 
embryonic development, the hematopoiesis that occurs later in the fetal liver and bone 
marrow is capable of generating all the blood lineages, including both myeloid 
lineages and lymphoid lineages. Since the hematopoiesis that occurs at these later 
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developmental stages generates smaller erythrocytes that only express adult 
hemoglobins, it is called definitive hematopoiesis. 
 
Figure 2. Hematopoietic organs at different developmental stages. The earliest 
hematopoietic organ is the yolk sac, and during later embryonic development, 
hematopoiesis moves to the AGM region (aorta, gonad, mesonephros region) and 
placenta. The first definitive hematopoiesis takes place in the fetal liver, and after 
birth, it moves to the bone marrow and thymus
2,3
. 
The whole blood-forming system is structured hierarchically. In fact, it is thought that 
many of the adult organs and tissues, not just the blood- forming system, are 
organized into hierarchies, where stem and progenitor cells are on the top and the 
mature cells are at the bottom. Stem cells are classified into two broad categories, the 
embryonic stem cell (ES cell) and the adult stem cell (also called somatic stem cell). 
ES cells are cell lines derived from the inner cell mass, a mass of pluripotent cells 
inside the blastocyst, whereas the adult stem cells reside in adult tissues and organs. 
Among all adult stem and progenitor systems, the hematopoietic system is one of the 
best understood, and it has served as one of the classical models for understanding 
adult stem and progenitor cells.  
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Self-renewal, a critical characteristic of stem cells, is the capacity of stem cells to 
undergo multiple cycles of cell division while maintaining an undifferentiated state
6,7
. 
When one stem/progenitor cell divides, three types of situations can occur at the 
single cell level (Figure 3)
6
: the first is one in which the stem cell undergoes 
symmetric self-renewal divisions, such that one stem cell divides to form two stem 
cells. In the second situation, the stem cell undergoes asymmetric self-renewal 
divisions, where a stem cell divides to form one daughter stem cell and one 
differentiated cell. In the third situation, the stem cell undergoes differentiation 
divisions, where a stem cell divides and forms two differentiated daughter cells 
(Figure 3). 
 
Figure 3. Different cell fates of stem cells after cell division. (A) When undergoing 
a symmetric self-renewal division, one stem cell divides and forms two stem cells. (B) 
When undergoing asymmetric self-renewal division, one stem cell divides and forms 
one daughter stem cell and one differentiated cell. (C) When undergoing 
differentiation division, one stem cell divides and forms two differentiated cells. (D) 
One stem cell undergoes quiescence and maintains its stem cell properties
6
.  
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In the past few decades, our understanding of the behavior of ES cells, including 
self-renewal, has greatly increased (Figure 4)
7–9
. The identification of essential 
pathways and important transcription factors and chromatin-modifying enzymes has 
significantly enhanced our ability to understanding the pluripotent state of these cells. 
Among all the critical factors identified, transcription factors NANGO, OCT4, and 
SOX2 are thought to be master regulators of stem cell properties (Figure 4) by 
positively regulating the expression of other proteins that contribute to the 
maintenance of stem cell properties
9
. These factors include transcription factors, such 
as HESX1, ZIC3, STAT3, POU5F1, histone and chromatin modifying enzymes, such 
as SMARCAD1, MYST3, and SET, signaling pathway downstream components, 
such as SKIL of the TGF-beta pathway, and NANGO, OCT4, and SOX2 themselves. 
In addition to their role in the positive regulation of these stem cell important factors, 
NANGO, OCT4, and SOX2 also negatively regulate the expression of factors that 
promote differentiation of ES cells towards different lineages. These factors include 
proteins that promote ES cells towards ectoderm differentiation, such as PAX6, 
MEIS1, HOXB1, LHX5, OTX1, factors that facilitate mesoderm and endoderm 
differentiation, such as HAND1, ONECUT1, ATBF1, and so forth. Through the 
positive regulation of factors required for maintenance of stem cell properties and the 
negative regulation of factors required for differentiation, NANGO, OCT4, and SOX2 
contribute to maintenance of stem cell properties and thus to ES cell self-renewal. 
Although great progress has been achieved in understanding ES cell properties, our 
understanding of the self-renewal property of stem and progenitor cells in adult 
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tissues and organs is extremely limited, significantly preventing potential therapeutic 




Figure 4. The regulation of ES cells by critical transcription factors. NANOG, 
OCT4, and SOX2 are essential transcription factors that maintain the stem cell 
properties of an ES cell. These transcription factors positively regulate ES cell 
important transcription factors including each other, and also negatively regulate the 




ES cells are cell lines that are easily expanded and thus it is relatively convenient to 
generate a large quantity of ES cells for further functional analysis, including 
ChIP-seq experiments that help to identify physical interactions between nuclear 
proteins and their binding DNA sequences. However, in comparison to ES cells, our 
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understanding of different types of adult stem/progenitor cells, such as cell surface 
markers to enrich these cells, and the capacities to collect enough materials for 
detailed molecular analysis, are extremely limited. 
We are just beginning to uncover the mysteries behind these cells. For example, we 
have identified a few critical proteins that contribute to self-renewal of some adult 
stem/progenitor cells, and we know that although different adult stem/progenitor cells 
use different molecules to control self-renewal properties, some critical factors are 
shared (Figure 5). These factors either contribute to the maintenance of the 
undifferentiated status of these cells or their continued proliferation. Together, these 
factors contribute to the regulation of self-renewal of adult stem/progenitor cells. 
 
Figure 5. The understanding of self-renewal of adult stem and progenitor cells is 
limited. In different tissues and organs, a few molecules have been identified as 
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Hematopoiesis is one of the most well studied adult stem and progenitor systems. 
Similar to other systems, hematopoiesis occurs hierarchically: the multipotent 
hematopoietic stem cell that has the potential to generate the whole blood-forming 
system is placed on the top of the hierarchy (Figure 6)
2,3,10
. In the fetal liver, the 
hematopoietic stem cell constantly undergoes both self-renewing and differentiation 
cell divisions to satisfy the embryonic needs for blood production; from E13 to E18 
the number of hematopoietic stem cells in the fetal liver increases ~20 fold and the 
fetal liver itself, ~80% of which is erythroid cells, also increases in size by a similar 
factor. In contrast, in the adult bone marrow the hematopoietic stem cell is normally 
quiescent and only divides when there is need for regeneration (Figure 2)
2,3
. 
In the past few years, many intermediate cells between the hematopoietic stem cell 
and the mature cells of all the blood lineages have been purified and enriched. A great 
amount has been learned from these cells, and hematopoiesis has served as a classic 
model system for understanding other adult stem/progenitor cell systems.  
The long-term self-renewing hematopoietic stem cell first divides and differentiates 
and generates short-term self-renewing hematopoietic stem cells and multipotential 
progenitor cells (MPP)
2,3
. MPPs then divide and differentiate and give rise to either 
the myeloid or lymphoid lineages through the formation of either the common 
myeloid progenitor (CMP) or the common lymphoid progenitor (CLP). The CLP 
further divides and differentiates leading to the formation of committed progenitors 
that give rise to all of the cells of the lymphoid lineage: T, B, natural killer (NK), and 
a subset of dendritic cells.  
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In contrast, the CMP produces progenitors that allow for the production of all other 
hematopoietic lineages, classified as myeloid or myeloerythroid cells. This includes 
erythrocytes, platelets, mast cells, neutrophils, eosinophils, basophils, monocytes, 
macrophages, and a subset of dendritic cells.  The CMP is able to differentiate into 
two potentially isolatable progenitor populations, which include the 
megakaryocyte-erythroid progenitor (MEP) and the granulocyte-monocyte progenitor 
(GMP).  The MEP and GMP give rise to lineage-committed progenitors that can 
undergo further differentiation to the particular lineages they are dedicated to – 
megakaryocytes and erythroid cells for the MEP and neutrophils, eosinophils, 
basophils, monocytes, and macrophages for the GMP. 
Recent studies challenge this traditional hierarchical model of hematopoiesis
11,12
. It 
has been suggested that the MEP may arise from a multipotent progenitor that then 
gives rise to the CLP and GMP progenitors, although subsequent work has suggested 
that this model alone may be oversimplified
13
. The majority of evidence supports the 
existence of the more traditional model of hematopoietic differentiation with the 
bifurcation between the myeloid and lymphoid lineages, although these recent studies 
suggest that some progenitor populations may be more heterogeneous and/or display 
more plasticity in differentiation than was once appreciated.   
An important molecular underpinning this increasing complexity in hematopoiesis 
can be attributed to the existence of lineage priming by transcription factors
11,14
. This 
concept arises from the finding that stem cells and multipotential progenitors express 
a number of lineage-specific transcription factors that are required for the generation 
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of specific mature lineages to which that progenitor is able to give rise. It is thought 
that this early expression of these transcription factors facilitates chromatin 
remodeling to maintain an open and permissive chromatin state that allows for 
differentiation of cells mediated by the underlying transcriptional program for that 
particular lineage. The existence of lineage priming may also underlie the ability of 
variations in transcription factor levels to mediate alterations in lineage choice or even 
reprogramming within the hematopoietic system. 
As a result of intensive studies, much is understood about the role of transcription 
factors in hematopoietic differentiation and particularly in myeloerythropoiesis. Much 
less is known of other types of regulatory proteins and noncoding RNAs such as 
micro RNAs that regulate these processes.  
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Figure 6. Hematopoiesis is a hierarchical differentiation process that leads to the 
formation of blood cells of all the blood lineages. Hematopoietic stem cells (HSC) 
can undergo self-renewing divisions. They can also divide and differentiate, leading 
to the formation of the common lymphoid progenitor (CLP) and the common myeloid 
progenitor (CMP). The CLP further differentiates and generates lymphocytes, 
whereas the CMP differentiates and forms the myeloid cells, including monocytes, 




Erythrocytes are important blood cells responsible for carrying oxygen from the lungs 
to other tissues of the body, and for the transport of carbon dioxide from the tissues to 
the lungs
15
. The earliest committed erythroid progenitor BFU-E responds to multiple 
 
Figure 7. Erythropoiesis is a multistage differentiation process. The hematopoietic 
stem cell (HSC) undergoes either self-renewal or differentiation divisions, where 
self-renewal leads to the formation of HSCs and differentiation leads to the formation 
of downstream hematopoietic progenitor cells, such as the CFU-GEMM. This 
hematopoietic progenitor cell then divides and differentiates, leading to the formation 
of the early erythroid progenitor (BFU-E), which further divides and differentiates 
and generates late erythroid progenitor (CFU-Es). Each CFU-E undergoes 3-5 cell 
divisions, differentiation, chromatin condensation, and enucleation, ultimately leading 
to the formation of the erythrocyte
16
. 
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hormones including EPO, IL-3, IL-6, GM-CSF (Granulocyte Macrophage Colony- 
Stimulating Factor) SCF (Stem Cell Factor), IGF-1 (Insulin- like growth factor 1), and 
divides to generate additional BFU-Es, through partial self- renewal, as well as later 
EPO- dependent CFU-E progenitors
16,17
. EPO binds to EPO receptors on the surface 
of committed erythroid CFU-E progenitors, blocking apoptosis and triggering a 
program of 4 – 5 terminal erythroid cell divisions, induction of hemoglobin, 
chromatin condensation, and enucleation (Figure 7)
18,19
. 
In adult humans, erythrocytes are made in bone marrow and circulate in the body for 
around 100 to 120 days. The daily loss of erythrocytes is 0.8% to 1% of the total 
circulating erythrocytes
15
 and the body produces around 2.5×10
11
 erythrocytes per day  
 
Figure 8. Erythropoiesis is regulated by a complex molecular network. At 
different developmental stages, erythropoiesis is regulated by different hormones. 
BFU-Es are regulated by IL-3, IL-6, SCF, Epo, glucocorticoids, and yet other 
hormones many of which are unknown. CFU-Es are regulated by Epo. Erythropoiesis 
is also regulated by many well- studied intracellular molecules such as transcription 
factors and small regulatory RNAs
16
. 
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to replenish this loss, a highly dynamic process that is regulated by multiple hormones 
at different developmental stages
16. While the mechanism behind EPO’s control of 
CFU-E apoptosis, proliferation, and terminal differentiation is well studied, we do not 
understand how the many hormones that regulate BFU-E progenitors, including EPO, 
stem cell factor (SCF), interleukin-3 (IL-3), and interleukin-6 (IL-6), interact to 
control BFU-E quiescence, self- renewal divisions, or cell divisions yielding the later 
CFU-E progenitors
16
 (Figure 8).  
Under stress conditions such as acute blood loss or chronic anemia, glucocorticoids 
trigger self-renewal of BFU-E progenitors in the spleen, and ultimately lead to 
increased BFU-E numbers and, over time, formation of increased numbers of CFU-E 
progenitors and of mature erythrocytes
17,20
. Although glucocorticoids have been 
clinically utilized to treat certain types of anemia, most notably Diamond–Blackfan 
anemia (DBA), severe side effects exist. Some examples of these side effects include 
muscle weakness, further weight gain, osteoporosis, diabetes, high blood pressure, 
and reduced growth in children. To date, our understanding of the molecular 
mechanisms behind glucocorticoid induced BFU-E self-renewal is extremely limited
21
. 
Understanding this process is one of the main goals of this thesis.  
5.4 Terminal erythroid differentiation and erythroblast enucleation 
Terminal erythropoiesis beginning at the CFU-E stage consists of several 
morphologically distinguishable stages, including the proerythroblast, basophilic 
erythroblast, orthochromatophilic erythroblast, reticulocyte, and erythrocyte. Two cell 
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surface markers have been widely used to distinguish these cells in mouse fetal liver 
in vivo (Figure 9)
22
. It has been shown that the expression of CD71, the transferrin  
 
Figure 9. CD71 and TER119 (glycophorin A) are two cell surface markers for in 
vivo terminal erythroid differentiation. Total fetal liver cells were stained with 
FITC-CD71 and PE-TER119 antibodies. Representative flow cytometry results are 
shown. Gates R1 to R5 represent different stages of erythroid differentiation, from the 
proerythroblast stage to the reticulocyte stage, where proerythroblasts and early 
basophilic erythroblasts are in R2, early and late basophilic erythroblasts are in R3, 
chromatophilic and orthochromatophilic erythroblasts are in R4, and late 
orthochromatophilic erythroblasts and reticulocytes are in R5
22
. 
  21 
 
Figure 10. In vitro erythroid progenitor culture system recapitulates essential 
characteristics of in vivo terminal erythropoiesis. Ter119- negative erythroblasts 
were purified from E14.5 fetal liver and cultured in vitro for 2 days in a differentiation 
medium with Epo. Day 0, day 1, and day 2 cultured cells were stained with 
FITC-CD71 and PE-TER119 antibodies. Representative flow cytometry results are 
shown. Benzidine-Giemsa staining of day 1 and day 2 cultured cells is shown; brown 
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receptor (CD-71), and glycophorin A (Ter-119 in the mouse) in erythroid progenitors 
follows a specific pattern: in the proerythroblast, both CD71 and glycophorin A are 
low, with the expression level of CD71 increasing during erythroid differentiation 
first and the expression level of glycophorin A increasing later. Finally, the expression 
level of CD71 goes down in the final stages of differentiation. This expression pattern 
is also faithfully reproduced during erythroid differentiation in in vitro culture of both 
fetal liver
22
 and adult erythroid progenitors
23
. These two cell surface markers 
therefore provide us a reliable method to trace the differentiation process. 
Furthermore, since the in vitro erythroid progenitor culture system recapitulates in 
vivo erythropoiesis, these markers also serves as platforms for the analysis of novel 
genes involved in regulating terminal erythropoiesis (Figure 10)
22
. 
Erythropoietin (Epo) is the principle hormone regulating erythropoiesis. In 1989, the 
cloning and characterization of the Epo receptor opened a critical window in 
deciphering how EPO regulates erythropoiesis
24
. As an example, a series of knockout 
animal studies showed that Epo and EpoR regulate erythropoiesis by contributing to 




Taking advantage of the unique expression pattern of the two cell surface proteins 
(CD71 and Ter119) that mark terminal erythropoiesis and the erythroid progenitor 
isolation and the in vitro culture system, further studies discovered several signaling 
pathways downstream of Epo and EpoR, the JAK-STAT pathway, the PI3K-AKT 
pathway, and the RAS-MAPK pathway. These pathways together regulate survival, 
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proliferation and differentiation of erythroid cells (Figure 11)
18,25
. In addition to 
Epo/EpoR and its downstream pathways, transcription factors also play important 
roles in regulating terminal erythropoiesis. These transcription factors include 





Figure 11. Epo and EpoR regulate survival of erythroid progenitors, and STAT5 
and BCL-X are important downstream mediators of EpoR signaling. On the left, 
in wild-type mice, growth or stress requirements trigger a maximum erythropoiesis 
rate. In the middle and on the right, in STAT5 knockout mice, loss of STAT5 leads to 
reduced production of erythrocytes
25
. 
During the last stage of terminal differentiation, erythroid cells undergo enucleation, 
during which erythroblasts extrude their nucleus
26
. The erythroblast first undergoes 
chromatin condensation before nucleus extrusion (Figure 12)
27
. During the extrusion 
process, the nucleus is surrounded by plasma membrane, and the whole process only 
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takes a few minutes. Pharmacological experiments together with time-lapse 
microscopy showed that the rearrangements of actin and other cytoskeleton systems 
and cytokinesis provide indispensible power in completing the nucleus extrusion 
process
26
. A tiny bud forms in the plasma membrane adjacent to the nucleus, and the 
nucleus gets pushed through this narrow gap, increasing the size of the bud. In the 
extrusion process the nucleus assumes an hourglass shape with bulges both in the 
cytosol and the budding nucleus; somehow actin filaments in the cytosol push the 
nucleus during this extrusion process. 
 
Figure 12. Actin cytoskeleton and nucleus structures during erythroblast 
enucleation. Fetal liver Ter119- erythroblasts were purified and in vitro cultured for 
45 hours in differentiation medium with Epo. Actin and nucleus staining during 
differentiation and enucleation are shown. Arrows in the right two panels point to the 
terminal actin ring, which separates the cytosol (green) and the blue nucleus
27
.  
After extrusion in vivo, nuclei are rapidly engulfed and degraded by nearby 
macrophages; only in culture systems free of macrophages do they accumulate. To 
easily monitor the enucleation process, a flow cytometry-based detection method has 
been established
27
. In this method, Ter119-negative erythroid progenitors are isolated 
and in vitro cultured in erythroid differentiation medium, after which cells are stained 
with both Ter119 and the DNA- staining Hoechst dye. As shown in Figures 13 and 14, 
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the nuclei are Ter119- and Hoechst+ (R6), the enucleated erythroblasts are Ter119+ 
and Hoechst- (R8) and the nucleated erythroblasts are double positive (R7).  
 
Figure 13. Flow cytometry based monitoring of erythroblast enucleation. Fetal 
liver Ter119- erythroblasts were purified and in vitro cultured for 2 days in a 
differentiation medium with Epo. Cultured cells from day 0, day 1, or day 2 were 





  26 
Figure 14. Visualization of the flow cytometry pattern of extruded nuclei, 
enucleated erythroblast, and nucleated erythroblast. Fetal liver Ter119- 
erythroblasts were purified and in vitro cultured 2 days in a differentiation medium 
with Epo. Day 2 cultured cells were stained with PE-TER119 and Hoechst. Indicated 
cell populations from R6, R7, and R8 gates were sorted and stained with 
Benzidine-Giemsa
27
. R6 are the extruded nuclei, R7 are the nucleated erythroblasts, 
and R8 comprise the enucleated reticulocytes 
 
Figure 15. Erythroblast enucleation requires the involvement of many cellular 
and molecular events. Chromatin condensation represents the first step of 
erythroblast enucleation, and nucleus extrusion represents the second step. 
Molecularly, the upregulation of HDACs and the downregulation of HAT (Gcn5) is 
required for chromatin condensation. Cytoskeleton regulators Rac and mDia2 control 
the second step, the formation of contractile actin ring and the extraction of nucleus
26
.    
With this novel flow cytometry method to monitor the enucleation process, a series of 
molecules have been identified and functionally characterized (Figure 15)
26
. We now 
know that enucleation is regulated by histone-modifying enzymes and the Rac 
GTPase; more specifically, the histone deacetylase HDAC2 and the histone 
acetyltransferase GCN5 control chromatin condensation, and Rac regulates the 
formation of the contractile actin ring at the boundary between the cytoplasm and the 
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extruding nucleus of late stage erythroblasts
27–30
. Although these protein mediated 
mechanisms are well-understood, far less is known about how other molecules, such 
as non-coding RNAs, are involved in the regulation of this critical step
31
. Identifying 
these small regulatory molecules is a goal of this thesis.  
5.5 Glucocorticoids and stress erythropoiesis 
Compared to terminal erythropoiesis, the early stages of erythropoiesis are less 
understood. It has been shown that IL-3, IL-6, stem cell factor (SCF) and Epo are 
required for the proliferation, differentiation, and survival of the early stages of 
erythroid progenitors
16
. Under stress conditions, such as bleeding, sepsis, genetic 
defects in late stages of erythropoiesis, or formation of unstable erythrocytes, the 
steroid hormone, glucocorticoid, and its nuclear receptor, the glucocorticoid receptor 
(GR) are required for the expansion of erythroid progenitors. However, it is not clear 




Recently, our lab established a novel cell sorting protocol to enrich both BFU-E and 
CFU-Es with high purity (Figure 16)
17
. In this protocol, hematopoietic cells were 
isolated from E14.5 mouse fetal liver and stained with biotin lineage panel and several 
hematopoietic stem/progenitor markers followed by magnetic separation. Negatively 
selected Lineage – negative cells were then stained with APC-CD117 (c-Kit) and 
FITC-CD71 (Transferrin receptor) and sorted into CD117high/CD71low population 
(BFU-Es) and a CD117high/CD71high population (CFU-Es). 
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Using these purified BFU-Es and CFU-Es, it has been found that glucocorticoid 




Figure 16. Novel FACS sorting protocol for enriched BFU-Es and CFU-Es. Fetal 
liver cells were isolated from E14.5 fetal liver and stained with a biotin lineage panel 
and several hematopoietic stem/progenitor markers followed by magnetic depletion. 
Negatively selected cells were further stained with APC-CD117 and FITC-CD71 and 




formation assays showed that glucocorticoids trigger the maintenance and often a 
small expansion of BFU-E colonies, consistent with observations from human CD34+ 
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stem/cells, where glucocorticoids triggers maintenance and expansion of BFU-Es, but 
not CFU-Es (Figure 18)
32
. Through bioinformatics analysis of the promoter and 
enhancer regions of glucocorticoid receptor target genes in murine BFU-E cells, our 
lab also found that these regions are enriched with potential binding sites for the 
hypoxia-inducible transcription factor HIF1 alpha, suggesting that hypoxia and HIF1 
alpha may synergizes with glucocorticoids to regulate BFU-E self-renewal
17
. Further 
experimental results proved this hypothesis, and our lab showed that HIF1 alpha 
activation by the prolyl hydroxylase inhibitor (PHI) together with glucocorticoids can 
trigger BFU-E expansion and generate 10 fold more CFU-E erythroid progenitor cells 
than glucocorticoids alone. This in turn leads over time in culture to the formation of a 
20 fold increase in production of erythroid cells. However, until my research we did 
not know whether any of the genes activated downstream of the glucocorticoid 
receptor or HIF1 alpha are involved in BFU-E self-renewal. 
 
Figure 17. Dexamethasone triggers long-term expansion of BFU-E, but not 
CFU-E. Purified BFU-Es and CFU-Es were cultured in the absence or presence of 
dexamethasone. The numbers of cells generated during the culture are shown
17
.   
Diamond Blackfan anemia (DBA) is congenital anemia, and in the bone marrow of 
DBA patients the number of both BFU-E and CFU-E progenitors are significantly less 
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than the numbers of these progenitors in normal individuals. Clinically, DBA patients 
do not respond to Epo treatment, because the body is already producing huge levels of 
this hormone, but do respond to glucocorticoids. By using the purified mouse BFU-Es 
and CFU-Es, we found that glucocorticoids triggers expansion of BFU-Es but not 
CFU-Es
17
. Therefore, at least part of the therapeutic effects of glucocorticoids comes 
from its direct effects on erythroid progenitor BFU-Es. This has been further 
supported by the observation that glucocorticoids support the expansion of RPS19 
deficient human CD34+ cells. Haploinsufficiency of RPS19 is a characteristic of 
DBA, and the RPS19 knockdown model recapitulates the growth defects of the 
erythroid cells of DBA patients. Therefore, the positive effects of glucocorticoids on 
the expansion of RPS19 deficient cells further support the conclusion that at least part 
 
Figure 18. Dexamethasone increases BFU-E colony formation. Human CD34+ 
cells were cultured in liquid for 3 days in the absence or presence of indicated 
concentrations of Dexamethasone. Cells were then plated in the methylcellulose 
medium and the numbers of BFU-E and CFU-E colonies were counted. * indicates 
p<0.05 and ** indicates p<0.01
32
. 
  31 
of the therapeutic effects of glucocorticoids on DBA patients treatments come from its 
direct effects on erythroid cell expansion (Figure 19)
32
. However, despite the facts 
that that glucocorticoids have been clinically used to treat DBA and that we know 
glucocorticoids contribute to erythroid progenitor BFU-E self-renewal, serious side 
effects of glucocorticoids treatment do exist and we need to better understand the 
molecular details how glucocorticoids regulate this process, which will potentially 
assist with the discovery of novel medicines to DBA. 
  
Figure 19. Dexamethasone increases the production of erythroid cells from 
human CD34+ cells expressing RPS19 shRNA. (A), RPS19 knockdown level in 
human CD34+ cells is shown by Western blot experiment. (B), Human CD34+ cells 
with knockdown of RPS19 were cultured for 10 days. The relative numbers of 




5.6 microRNAs in erythropoiesis 
microRNAs are a class of small non-coding RNAs involved in the regulation of many 
biological processes through the downregulation of multiple target genes
33–36
. Primary 
miRNAs are transcribed and processed by Drosha and DGCR8 to form pre-miRNAs. 
pre-miRNAs are transported out of nucleus by RAN-GTP and Exportin-5 and further 
processed by Dicer and loaded into a RISC complex. The RISC binds to target 
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mRNAs and leads to either translational repression or mRNA destabilization, and 
microRNAs recognize target genes through binding of their 6 – 8 base “seed 
sequences” near their 5’ ends to the complementary sequences in the 3’UTRs of their 




Figure 20. microRNAs function as posttranscriptional regulators for gene 
expression. Primary miRNAs are transcribed and processed by Drosha and DGCR8 
to form pre-miRNAs. pre-miRNAs are transported out of the nucleus by RAN-GTP 
and Exportin-5 and further processed by Dicer and loaded into a RISC complex. The 




The first evidence that microRNAs play important roles in the blood-forming system 
came from the discovery that miR-181 was preferentially expressed in B-lymphoid 
cells and that overexpression of miR-181 in hematopoietic stem/progenitor cells leads 
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to an increased B-lineage cell fraction
38
. Since then microRNAs have been implicated 
in the formation of multiple blood cell lineages. In recent years, a few microRNAs 
have also been specifically linked with erythropoiesis
16,31
. These are shown in Figure 
21 and Table 1 and detailed below; much of the material below is taken from a recent 




Figure 21. microRNAs are important regulators of erythroid cell production and 
megakaryocyte–erythroid progenitor (MEP) lineage commitment. Up arrows 
represent upregulation of microRNAs or protein-coding genes. Down arrows 




miR-144 and miR-451 are co-transcribed miRNAs highly induced in the erythroid 
cell line G1E-ER4 when the important erythroid transcription factor, GATA-1, is 
restored by treatment with estradiol. This is consistent with the observations that 
  34 
miR-144 and miR-451 are upregulated during erythroid differentiation of human 
CD34+ and murine erythroleukemia (MEL) cells
39
. In both G1E-ER4 and MEL cells  
Table 1. The summary of the experimental system used in the study of red cell 
formation, the normal developmental function, and the target genes of 




and primary mouse fetal liver cells, chromatin immunoprecipitation (ChIP) 
experiments demonstrated that GATA-1 binds a genomic locus 2.8 kb upstream of 
miR-144/451, a region containing a predicted GATA-1 binding motif. Furthermore, 
luciferase reporter assays suggested that this motif is indeed a functional erythroid 




In zebrafish, knockdown of miR-451 by an antisense morpholino impairs 
erythropoiesis, which suggested an important functional role of miR-451 in 
erythropoiesis
39,40
. Erythropoietic defects have also been observed in mnr, a 
nonanemic zebrafish mutant with reduced expression of miR-144/451. By injection of 
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a GFP reporter containing the Gata2 3’UTR into zebrafish embryos, the authors 
showed that Gata-2 expression is downregulated by and is a potential target of 
miR-144/451. Injection of a Gata2 morpholino partially rescued the erythroid 
 
Figure 22. miR-144/451 is a direct target gene of GATA1. (A) The genomic locus 
of miR-144/451 and the ChIP-PCR primers for B and C are shown. (B) The 
ChIP-PCR results of GATA-1, FOG-1, and GATA-2 for G1E and G1E-ER4 cells are 
shown. (C) The ChIP-PCR results of GATA-1 and FOG-1 in fetal liver and MEL 
cells are shown. (D) The ChIP-PCR results of polII is shown
39
.  
differentiation defects of the mnr mutant, further confirming that Gata-2 is a direct 
target of miR-451
40
. In contrast to miR-451 morpholino injected embryos, zebrafish 
embryos injected with miR-144 locked nucleic acids (LNAs) to reduce miR-144 
expression are morphologically normal. By using in situ hybridization to detect the 
expression of several hematopoietic- and vascular- specific genes, the authors found 
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that embryonic alpha-globin expression was significantly upregulated in miR-144 
LNA injected embryos. In vivo reporter assays suggested that Klfd might be a target 
of miR-144. ChIP experiments demonstrated that Klfd binds to the promoter region of 
miR-144 and alpha-globin. Together, this suggested that miR-144 and Klfd form a 
negative feedback loop modulating the expression of an embryonic form of 
alpha-globin: Klfd induces miR-144 (and miR-451) expression, and miR-144 
downregulates Klfd (Figure 23)
41
.  This model of globin regulation by miR-144 
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Figure 23. mnr mutant Zebrafish shows defects in erythropoiesis. (A) The 
expression pattern of hemoglobin in wild type and mnr mutant Zebrafish. (B) 




Recently, several groups created miR-144/451 or miR-451 knockout mice
42–44
. 
miR-144/451 knockout mice displayed moderate erythroid hyperplasia, moderate 
splenomegaly, and mild anemia. When exposed to phenylhydrazine, more than half of 
the miR-144/451
-/-
 mice died from the resulting hemolytic anemia, whereas all of the 
wild type mice fully recovered, which suggests that the knockout mice have an 
impaired response to oxidative stress
42–44
. One direct target gene of miR-451 is 
14-3-3, a phospho-serine/threonine-binding protein43,44 that inhibits nuclear 
accumulation of the transcription factor FoxO3, a positive regulator of erythroid 
anti-oxidant genes. As a result, the abnormal accumulation of 14-3-3 in 
miR-144/451
-/-
 erythroblasts causes a partial relocalization of FoxO3 from nucleus to 
cytoplasm (Figure 24)
43
 and dampens the expression of several FoxO3 target genes 
that encode important anti-oxidant proteins, including Cat and Gpx1. shRNA 
suppression of 14-3-3 has been shown to protect miR-144/451-/- erythrocytes against 
peroxide-induced destruction
43
. Together, these results suggest that miR-451 is 
critical for protecting erythroid cells against oxidant stress. While, the miR-451 
knockout mice only display a subtle anemia, the importance of this microRNA in 
ensuring optimal differentiation of erythrocytes that are capable of mounting a robust 
anti-oxidant response is well demonstrated through these elegant in vivo studies.  
Interestingly, recent work has shown that the maturation of miR-451 does not require 
Dicer, but instead relies on the enzymatic activity of Ago2. Consistent with the 
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Figure 24. The nuclear accumulation of FoxO3 in erythroblasts of miR-144/451 
knockout mice. (A) The mRNA expression levels of FoxO3 in Ter119+ erythroblasts 
from wild type mice and miR-144/451 knockout mice. (B) The protein expression 
levels of FoxO3 in Ter119+ erythroblasts from wild type mice and miR-144/451 
knockout mice. (C) Immunofluorescence staining of FoxO3 in Ter119+ erythroblasts 
from wild type mice and miR-144/451 knockout mice. (D) Quantitative summary of 




anemic phenotype of miR-144/451 knockout mice, Ago2 knockout mice die shortly 
after birth from anemia. These mice exhibit dysregulation of expression of miR-451, 
suggesting that this dysregulation contributes to the anemic phenotype of Ago2 
knockout mice
45
. However, this work is controversial given the dramatically different 
phenotypes seen in the two knockout animals
42–45
. The Ago2 knockout animals have a 
severe fetal anemia, whereas a knockout of miR-451 has very subtle effects. Further 
work is necessary to better understand the physiological role of these microRNAs in 
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erythropoiesis and is likely to uncover critical reasons for the evolutionary 
conservation of these microRNAs. 
miR-221/222  
Originally identified as microRNAs downregulated during erythroid differentiation of 
human cord blood CD34+ cells, miR-221 and miR-222 are important regulators of 
early erythroid proliferation
46. The 3’UTR of KIT contains sequences complementary 
to the similar miR-221 and miR-222 seed sequence and these sequences are 
responsive to miR-221 and miR-222 in luciferase reporter assays. This suggests that 
KIT, the stem cell factor (SCF) receptor and an important regulator of early erythroid 
progenitor proliferation, may be a direct target downregulated by miR-221 and 
miR-222. In erythroid cultured human cord blood CD34+ cells, miR-221 and 
miR-222 are normally downregulated during erythroid differentiation, and 
overexpression of these two microRNAs by either oligonucleotide transfection or 
lentiviral infection impairs erythroid progenitor expansion and accelerates erythroid 
differentiation, accompanied by a decrease in KIT expression. These data suggest that 
miR-221 and miR-222 together with KIT form a regulatory cascade involved in 
balancing erythroid progenitor expansion and erythroid differentiation
46
. The 
physiological importance of these microRNAs in in vivo erythropoiesis remains to be 
established by study of gene- altered mice. 
miR-24 
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miR-24 is a negative regulator of activin type I receptor ALK4
47, and the 3’UTR of 
ALK4 contains sequences complementary to miR-24. Indeed, luciferase reporter 
assays demonstrated that the 3’UTR of ALK4 is miR-24 responsive, and in HEK293 
cells, overexpression of miR-24 downregulated the expression of ALK4. In contrast, 
overexpression of miR-24 impaired activin-triggered Smad2 phosphorylation and 
activin-induced luciferase reporter activity, indicators of a defect in activin signaling. 
In K562 cells, activin A functions as a positive regulator of erythropoiesis and induces 
the accumulation of hemoglobin. Overexpression of miR-24 partially blocked the 
accumulation of hemoglobin, whereas knockdown of miR-24 slightly promoted it. 
This negative effect of miR-24 on erythropoiesis has further been suggested by data 
from primary human CD34+ HPCs where overexpression of miR-24 impaired 
erythropoiesis and knockdown of miR-24 promoted it, as indicated both by erythroid 
colony formation assays and a liquid culture erythroid differentiation assay. Together, 
these data suggested that miR-24 negatively regulates erythropoiesis through 
downmodulating the activin signaling pathway
48
. The in vivo function of miR-24 
remains to be tested to better understand the physiological significance of this 
microRNA. 
miR-15a, miR-16-1 and miR-16-2 
Initially, miR-15a had been identified as a microRNA that downregulates MYB 
expression
49; the 3’UTR of MYB contains sequences complementary to the miR-15a 
seed sequence. Further luciferase reporter assays suggested that the 3’UTR of MYB is 
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indeed miR-15a responsive. Interestingly, in K562 cells, ChIP experiments suggested 
that MYB binds to the promoter region of miR-15a, suggesting that myb enhances 
transcription of the miR-15a gene. Overexpression of miR-15a downregulated MYB 
expression at the protein level whereas knockdown of miR-15a upregulated MYB  
 
Figure 25. Overexpression of miR-15a/16-1 in human erythroid cells increases 
the expression of fetal hemoglobin. (A-C) The percentage or relative expression 
level of fetal hemoglobin in erythroid cells with overexpression of indicated 
constructs. (D) Representative cytospin staining of erythroid cells with overexpression 
of indicated constructs. (E-F) Cell cycle analysis of day 4 and day 7 cultured erythroid 
cells with overexpression of indicated constructs
49
. 
expression. The regulation of miR-15a expression by MYB also has been shown in 
K562 cells where knockdown of MYB impairs miR-15a expression. This data 
suggested that there exists an auto-regulatory loop between miR-15a and MYB, in 
which MYB promotes expression of miR-15a, and that this microRNA in turn 
downmodulates MYB expression
49
. During erythroid differentiation of cultured 
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human primary CD34+ hematopoietic progenitor cells (HPCs) the expression patterns 
of MYB and miR-15a were inversely correlated with each other. Overexpression of 
miR-15a in human bone marrow mononuclear cells or CD34+ cells impaired 
formation of CFU-E and CFU-GM colonies and had a modest effect on BFU-E 
colony formation. These data suggested that this auto-regulatory feedback loop 
between miR-15a and MYB is involved in normal hematopoietic regulation
49
.  
Importantly, a recent discovery has linked, via its target MYB, the miR-15a and 
miR-16-1 microRNA cluster with a certain phenotype of human trisomy 13: an 
additional chromosome copy of human trisomy 13 results in abnormal upregulation of 
the human   (Figure 25). This segment of 
chromosome 13 contains the miR-15 and miR-16 genes; the abnormal upregulation of 
these microRNAs leads to downregulation of their target gene MYB, which in turn 
elevates fetal hemoglobin expression
4
.  Since increased fetal hemoglobin is 
important to ameliorate the symptoms of sickle cell disease and beta-thalassemia, 
alteration of miR-15a/16-1 expression or MYB expression may be useful for 
developing more targeted therapeutic approaches to treat these conditions
50
. Other 
recently published work has linked miR-16-2 with the regulation of erythropoiesis; 
the pathological upregulation of miR-16-2 may contribute to the abnormal expansion 
of erythroid cells in polycythemia vera
50
.  This finding needs to be confirmed. 
Furthermore, the in vivo role of these microRNAs in normal erythropoiesis remains to 
be established.   
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miR-150 
Using microRNA expression profiling of purified human umbilical cord blood 
hematopoietic progenitors, miR-150 was found to be enriched in MEPs and 
megakaryocyte progenitors relative to erythroid progenitors
51
. In the human CD34+ 
hematopoietic stem/progenitor cell culture system, in which erythropoietin (EPO) and 
thrombopoietin (TPO) promote differentiation towards the erythrocyte and 
megakaryocyte lineages, respectively, overexpression of miR-150 resulted in a 8-fold 
increase of megakaryocytic cells. That miR-150 promotes megakaryocyte formation 
was further supported by data from in vivo hematopoietic stem/progenitor cell 
transplantation assays, where overexpression of miR-150 resulted in a more than 
15-fold increase of megakaryocytes and a 60% decrease of erythroid cells (Figure 26). 
In addition, overexpression of miR-150 increases colony-forming unit megakaryocyte 
(CFU-Mk) formation and decreases colony-forming unit erythroid (CFU-E) formation. 
In contrast, antagomir triggered loss-of-function of miR-150 decreased CFU-Mk 
formation. Together, these results indicate that miR-150 is important for promoting 
MEP lineage determination (Figure 26).  
Furthermore, the level of miR-150 was dramatically decreased during 
phenylhydrazine induced acute anemia, where rapid erythroid reconstitution is 
required, suggesting that the expression of miR-150 is regulated by the physiological 
environment
52
. MYB is a target gene of miR-150 and MYB downregulation would be 
one mechanism by which this miRNA promotes formation of megakaryocytes at the 
expense of erythroid progenitors. The 3’UTR of MYB contains a miR-150 binding site 
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that is responsive to miR-150 in luciferase reporter assays. Moreover, overexpression 
of miR-150 in the erythroleukemia cell line K562 reduced MYB expression. In 
addition, shRNA knockdown of MYB in human CD34+ cells promotes 
megakaryocytic cell production mimicking the miR-150 overexpression phenotype. 
Together, this work suggested that miR-150 and MYB form a regulatory network 
involved in the lineage determination of the bi-potential MEP
52
.   
 
Figure 26. miR-150 regulates megakaryocyte and erythrocyte development. (A) 
A miR-150 construct or control construct was infected into hematopoietic 
stem/progenitor cells and transplanted into irradiated recipient mice. (B-C) 
Overexpression of miR-150 leads to an increased percentage of megakaryocytes and 
decreased percentage of erythrocytes. (D) Representative flow cytometry plots of 
megakaryocyte and erythrocyte markers. (E) Bone marrow cells were sorted and the 
expression of PF4, a platelet marker protein, were analyzed for either control or 
miR-150 overexpression mice. (F) The circulating platelets were analyzed. (G) 
Representative erythroid differentiation flow cytometry plots were shown. (H-I) The 
relative ratio of erythroid cells in R1 and R4 gates were shown
52
.   
  45 
Both miR-150 and miR-15a target MYB, the partial knockdown of which causes 
thrombocytosis and anemia. While overexpression of miR-150 blocks the 
commitment of MEPs to the erythroid lineage, enforced expression of miR-15a 
impairs the erythroid differentiation from the BFU-E to the CFU-E stage. This is an 
interesting example that illustrates how multiple microRNAs regulate the expression 
of the same gene at sequential developmental stages, contributing to lineage 
specification and further differentiation. In this scenario, the downregulation of 
miR-150 from MEP to erythroid progenitor promotes the commitment of MEPs to the 
erythroid lineage through the upregulation of MYB, and miR-15a fine-tunes the level 
of MYB in erythroid progenitors and modulates erythroid differentiation. It will be 
interesting to determine the precise expression patterns of miR-15a in MEP and 
megakaryocytic progenitors, and to elucidate whether miR-15a is also involved in the 
MEP lineage specification, in addition to its role in erythroid differentiation.    
From the results described above, it is clear that a great deal has been learned about 
the role of microRNAs in erythroid differentiation and MEP lineage commitment over 
the past few years. Traditionally, it has been thought that the production of erythroid 
cells are regulated by cytokines, including EPO, IL-3, IL-6, SCF, and glucocorticoids. 
These extracellular molecules activate several intracellular downstream signaling 
pathways, including the JAK/STAT, RAS/MAPK, and PI3K/AKT pathways, all of 
which eventually regulate transcription factors, such as GATA1, TAL1/SCL, STAT5, 
and KLF1, to ultimately modulate the expression of genes required for lineage 
commitment and differentiation. The discovery that microRNAs are required for 
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erythroid and megakaryocytic cells formation uncovers another layer of this 
regulatory mechanism.  
One type of this microRNA-mediated regulation influences the ‘decision-making’ 
process through fine-tuning of the expression of key regulatory molecules. An 
intricate example of this type of regulation is visible in the participation of miR-150, 
miR-15a, and their target gene MYB in MEP lineage commitment and further 
erythroid differentiation. MYB is critical for MFP lineage commitment and erythroid 
differentiation, and partial loss of MYB expression promotes thrombocytosis and 
subtle erythroid abnormalities. However, it is not clear how its meticulous expression 
pattern, expressed higher in MEPs and early erythroid progenitors than in 
megakaryocytic progenitors, and gradually downregulated during further erythroid 
differentiation, is achieved. The identification of miR-150 and miR-15a as 
microRNAs that target MYB at sequential stages of MEP lineage commitment and 
erythroid differentiation provides one possible explanation. In this case, the higher 
expression levels of miR-150 in MEP and megakaryocytic progenitors modulate the 
destiny of such cells. The daughter cell of a MEP that ‘inherits’ an increased level of 
miR-150 will be more likely to become a megakaryocytic progenitor, and its 
counterpart with lower levels of miR-150 will be more likely to be an erythroid 
progenitor. This hypothesis is supported by experimental evidence detailed above, 
although further studies of such regulatory mechanisms are needed. And following the 
MEP stage, the upregulation of miR-15a/16-1 may allow for modulation of MYB 
expression during erythropoiesis.  
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Another type of microRNA-mediated regulation mainly contributes to the robustness 
of biological systems that control erythroid and megakaryocytic cell production. A 
well-studied example is miR-451, where mice with a knockout of this microRNA 
have a rather subtle phenotype and on its own, this molecule does not appear to 
contribute in a major way to normal homeostatic erythropoiesis. However, during 
phenylhydrazine-induced hemolytic anemia, where the demand for erythrocyte 
production and the resistance to peroxide-induced destruction is greatly elevated, 
miR-451 becomes indispensible for erythrocyte production. 
In conclusion, despite these findings on the roles of microRNAs on erythroid 
differentiation and MEP lineage commitment, our understanding of the potential roles 
of microRNAs in erythropoiesis, particularly erythroblast chromatin condensation and 
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6. ZFP36l2 is required for self-renewal of early erythroid BFU-E progenitors
53
 
Red cell production is closely regulated by multiple hormones that affect several types 
of progenitors. Apoptosis, proliferation, and terminal differentiation of CFU-E 
erythroid progenitors are mainly controlled by the hormone erythropoietin (EPO)
19,54
; 
in contrast, BFU-E progenitors are regulated by many hormones including EPO, stem 
cell factor (SCF), interleukin-3 (IL-3), and interleukin-6 (IL-6). However, it is not 
clear how they interact to control BFU-E quiescence, self- renewal divisions, or the 
cell divisions that yield the later CFU-E progenitors. Under stress conditions, 
glucocorticoids trigger self-renewal of BFU-E progenitors, resulting in increased 
numbers of self- renewal divisions. This results in increased BFU-E numbers and, 




6.1 Results and discussion 
6.1.1 ZFP36l2 is normally downregulated during erythroid differentiation from 
the BFU-E stage and this downregulation is reversed by functional GR agonists. 
To identify genes downstream of the GR that are essential for BFU-E self-renewal, 
BFU-Es were purified
17
 and cultured in a medium (self-renewal medium) containing 
SCF, EPO, insulin-like growth factor 1 (IGF-1), and several full or dissociated GR 
agonists. All agonists, except for one dissociated agonist, stimulate BFU-E 
self-renewal (Figure 27). Since the genes upregulated by all functional agonists 
represent candidates indispensable for BFU-E self-renewal, we performed deep 
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sequencing on mRNAs from BFU-Es cultured with GR agonists for 4 hours, and 
identified a group of genes upregulated by all functional agonists but not by 
nonfunctional agonists. We focused on three genes normally downregulated during 
erythroid differentiation, Zfp36l2, Hopx, and Nlrp6 (Figure 28, b, c). As detailed later, 
knockdown of Hopx and Nlrp6 resulted in a defect in BFU-E proliferation. In contrast, 
knockdown of Zfp36l2, the most abundant transcript upregulated by GR agonists, did 
not affect the initial rate of BFU-E division.  
During erythroid differentiation in vivo, zfp36l2 is downregulated from the BFU-E 
stage (Figure 29, a, b). BFU-Es cultured in vitro for 4 hours with all functional GR 
agonists exhibited a ~2.5 fold upregulation of zfp36l2 that was maintained 
 
Figure 27. The effects of full and dissociated GR agonists in supporting BFU-E 
self-renewal divisions. BFU-Es were cultured in self-renewal medium with indicated 
GR agonists and, as described previously the numbers of cells generated at day 9 were 
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measured. The maximum response of BFU-Es to DEX was shown as a plateau that 
started at 12nM and was maintained at concentrations up to 1000nM. An average cell 
number was calculated for these culture conditions. The relative cell number is a ratio 





Figure 28. The effects of knockdown of c-Kit, Hopx, and Nlrp6 on BFU-E in vitro 
expansion. BFU-Es were infected with viruses encoding indicated shRNAs and 
cultured in self-renewal medium with or without DEX. The relative cell numbers 
throughout the culture are shown. Error bar represents SD of 3 biological repeats. a, 
The effects of knockdown of c-Kit are shown. b, The effects of knockdown of Hopx 
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Figure 29. The normal downregulation of ZFP36l2 during erythroid 
differentiation from the BFU-E stage is reversed by functional GR agonists. a, 
The expression levels of zfp36l2 in BFU-Es, CFU-Es, and Ter119+ erythroblasts were 
measured by RNA-seq. b, The expression levels of zfp36l2 in BFU-Es and CFU-Es 
were measured by RT-PCR normalized to 18 S rRNA. Error bar represents standard 
deviation (SD) of 3 biological repeats. P-value was calculated using the two-tailed 
t-test. c, The expression levels of zfp36l2 in BFU-Es after 4 hours culture in 
self-renewal medium with indicated GR agonists were measured by RNA-seq. d, The 
expression levels of zfp36l2 in BFU-Es after 3 days culture in self-renewal medium 
with or without DEX were measured by RT-PCR normalized to 18 S rRNA. Error bar 
represents SD of 3 biological repeats. P-value was calculated using the two-tailed t-test. 
e, The expression level of ZFP36l2 in BFU-Es after 3 days culture in self-renewal 
medium with or without DEX was measured by Western blot. Representative data of 
3 biological repeats is shown. f, The expression levels of zfp36, zfp36l1, and zfp36l2 
in BFU-Es, CFU-Es, and Ter119+ erythroblasts were measured by RNA-seq; data 
shown are relative RPKM (reads per kilobase per million mapped reads) values 
normalized to the expression level of ZFP36 in Ter119+ erythroblasts. g, Luciferase 
reporter vector cloned with each GR binding site or empty vector were co-transfected 
with XZ-GR into 293T cells and cultured in a medium containing 1uM DEX, and 
luciferase activities were measured 2 days later. Error bar represents standard 




throughout the culture (Figure 29, c, d, e). Given that zfp36l2 is upregulated after only 
4 hours, zfp36l2 is likely a direct transcriptional target of the GR. Thus we performed 
GR chromatin immunoprecipitation sequencing (ChIP-seq) on freshly isolated 
BFU-Es after a 1 hour stimulation with dexamethasone (DEX) and identified five GR 
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binding sites near the Zfp36l2 transcription start site (TSS), which are potential 
enhancers of Zfp36l2 (Figure 30). Four of these binding sites responded to DEX, 
indicating that they are functional enhancers regulated by glucocorticoids (Figure 
29g). Together, these results suggest that ZFP36l2 is a direct transcriptional target of 
the GR in BFU-Es. 
ZFP36l2 belongs to an RNA binding protein family
56
. Based on RNA-seq gene 
expression data from purified BFU-E, CFU-E, and Ter119-positive (Ter119+) 
erythroblasts
17
, zfp36l2 is ~20 times more abundant in erythroid progenitors than its 
other two family members, zfp36 and zfp36l1, and is the only member upregulated by 
DEX (Figure 29f and Figure 31). This suggests that ZFP36l2 is the major family 
member involved in regulation of BFU-E self-renewal. Furthermore, zfp36l2 is 
gradually downregulated from the hematopoietic stem cell (HSC) stage to the early 
and late erythroid progenitor stages (Figure 32). In summary, 
 
Figure 30. The results of GR ChIP-seq on BFU-Es are shown schematically. 
Peaks are indicated as black bars. The location of the ZFP36l2 and adjacent The 
Thada gene is indicated; thick bars denote coding sequences
53
.  
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Figure 31. The expression levels of zfp36, zfp36l1, and zfp36l2 in BFU-Es after 4 
hours culture in self-renewal medium with or without DEX. Expression levels 
were measured by RNA-seq
10
; data shown are relative RPKM values normalized to 





Figure 32. The relative expression levels of zfp36l2 in different hematopoietic 
cells
33
. Hematopoietic stem cells (HSC1, 2), megakaryocyte/erythroid bipotential 
progenitor (MEP), and erythroid cells (ERY1-5) are depicted. The expression is 
normalized to a mean expression of zero across all the hematopoietic samples as 
mentioned before
33
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glucocorticoid treatment of BFU-Es reverses the normal downregulation of zfp36l2, 
correlating with glucocorticoid-induced BFU-E self-renewal. 
6.1.2 ZFP36l2 is specifically required for BFU-E self-renewal.  
To test whether upregulation of ZFP36l2 is required for glucocorticoid-induced 
BFU-E self-renewal, we used two shRNAs to knock down expression of ZFP36l2 
 
Figure 33. ZFP36l2 is specifically required for BFU-E self-renewal. a, The 
expression levels of zfp36l2 in BFU-Es infected with viruses encoding indicated 
shRNAs followed with 1 day culture in self-renewal medium with DEX were 
measured by RT-PCR normalized to 18 S rRNA. Error bar represents SD of 3 
biological repeats. P-values were calculated using the two-tailed t-test. b, The 
expression levels of ZFP36l2 in BFU-Es infected with viruses encoding indicated 
shRNAs followed by 3 days culture in self-renewal medium with DEX were 
measured by Western blot. Representative data of 3 biological repeats is shown. c, 
BFU-Es were infected with viruses encoding indicated shRNAs and cultured in 
self-renewal medium with or without DEX. The relative cell numbers throughout the 
culture are shown. Error bar represents SD of 3 biological repeats. d, Day 3 cells from 
this in vitro BFU-E culture system were plated in  methylcellulose medium; BFU-E 
colonies were counted 9 days later. Error bar represents SD of 3 biological repeats. 
P-values were calculated using the two-tailed t-test. e, Day 3, 4, and 5 cells from this in 
vitro BFU-E culture system were stained with Annexin V and 7-AAD and the 
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in BFU-Es (Figure 33, a, b). BFU-Es cultured without DEX stop proliferating at 4 
days; as shown previously
17
, in the absence of DEX each BFU-E generates several 
CFU-Es, each of which generates 10-30 erythroid cells over a 5 to 6 day period. In 
contrast, BFU-Es cultured in the presence of DEX continue to proliferate and generate 
over 10 times more mature erythroid cells at 9 days of culture. As shown previously
17
, 
in the presence of DEX each BFU-E generates multiple daughter BFU-Es during the 
first days of culture; over time these BFU-Es generate increased numbers of daughter 
CFU-Es, each of which generates 10-30 erythroid cells. Importantly, BFU-Es 
expressing either ZFP36l2 shRNA stop proliferating at day 4, whether or not DEX is 
included; the proliferation kinetics are similar to those of BFU-Es cultured without 
DEX (Figure 33c). This suggests that knockdown of ZFP36l2 disrupts DEX-induced 
self-renewal of BFU-Es.  
As one control, knockdown of c-Kit, a cell surface receptor required for the survival 
of hematopoietic stem and progenitor cells including BFU-Es, resulted in a blockage 
of BFU-E proliferation after only 1 day of culture (Figure 28a). Hopx and Nlrp6 share 
similar expression patterns as zfp36l2, are downregulated during erythroid 
differentiation from the BFU-E stage and upregulated by Dex, and possess promoter 
regions that, based on our GR ChIP-Seq data, are occupied by GRs. Knockdown of 
these also resulted in a blockage of BFU-E proliferation after only 1 day of culture. 
(Figure 28 b, c)  
To establish that ZFP36l2 is specifically required for BFU-E self-renewal, three - day 
BFU-E cultures were tested for their number of daughter BFU-Es by colony assays. 
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Knockdown of ZFP36l2 significantly decreased the number of BFU-Es formed in the 
presence of DEX (Figure 33d). Knockdown of ZFP36l2 had no influence on apoptosis 
of BFU-Es (Figure 33e) and, as expected based on its low level of expression in 
CFU-E cells, knockdown of ZFP36l2 had no effect on erythroid differentiation 
beyond the CFU-E stage (Figure 34). These data suggest that ZFP36l2 is specifically 
required for glucocorticoid-induced BFU-E self-renewal.  
 
Figure 34. The effects of knockdown of ZFP36l2 on CFU-E differentiation. 
Ter119- erythroid progenitors were isolated from E14.5 mouse fetal liver and infected 
with viruses encoding indicated shRNAs and cultured in differentiation medium. The 





6.1.3 ZFP36l2 is required for erythroid lineage expansion during stress 
erythropoiesis in vivo. 
Glucocorticoids and GR are required for erythroid lineage cell expansion in the spleen 
during stress erythropoiesis
20,57
. The data in Figure 35, using a phenylhydrazine 
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Figure 35. ZFP36l2 is required for erythroid lineage expansion during stress 
erythropoiesis in vivo. a, Schematic diagram shows the in vivo bone marrow 
transplantation and PHZ induced hemolytic anemia mouse model. b, Corticosterone 
levels were measured in mouse plasma 1 hour after PHZ injection. Error bar 
represents SD of 3 biological repeats. P-value was calculated using the two-tailed t-test. 
c, The normalized numbers of each type of GFP+ hematopoietic lineage cells were 
calculated as a ratio of the number of each type of GFP+ hematopoietic lineage cells 
in the spleen relative to the percentages of GFP+ cells in the Lin- population before 
transplantation. In all cases P-values were calculated using the two-tailed t-test. The 
normalized numbers of GFP+ Ter119+ cells are shown. d, The normalized numbers 
of GFP+ CD11b+ cells are shown. e, The normalized numbers of GFP+ Gr-1+ cells 
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Figure 36. Knockdown of ZFP36l2 in the mouse transplantation model. a, Lin- 
cells were isolated from E14.5 mouse fetal liver and infected with viruses encoding 
GFP and either a control shRNA or ZFP36l2 shRNAs. The levels of ZFP36l2 were 
measured in Lin- cells before transplantation by RT-PCR normalized to 18 S rRNA. 
Error bar represents SD of 3 biological repeats. P-values were calculated using the 
two-tailed t-test. b, The percentages of GFP+ cells were measured in these Lin- cells 
before transplantation. Each dot represents one biological repeat. c, 6 to 8 weeks after 
transplantation, the recipient mice were intraperitoneally injected with 60 mg/kg PHZ 
or control PBS on day 0 and day 1. On day 4, spleens were dissected and measured 
for percentages of GFP+ cells. The normalized percentages of GFP+ cells is 
calculated as a ratio of the percentage of GFP+ cells relative to the percentages of 
GFP+ Lin- cells in the Lin- population before transplantation of mice injected with 
control PBS. P-values were calculated using the two-tailed t-test. d, The normalized 
percentages of GFP+ cells of mice injected with PHZ and control PBS are shown. 
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Figure 37. Representative flow cytometry analyses of GFP+ Ter119+ cells in the 
recipient mice. Lin- cells were isolated from E14.5 mouse fetal liver, infected with 
viruses encoding GFP and either a control shRNA or ZFP36l2 shRNAs, and 
transplanted into lethally irradiated recipient mice. 6 to 8 weeks after transplantation, 
the recipient mice were intraperitoneally injected with 60 mg/kg PHZ on day 0 and 
day 1. On day 4, spleens were dissected and measured for percentages of Ter119+ 
GFP+ cells. Representative flow cytometry results are shown, and percentages of 




(PHZ) induced hemolytic anemia mouse model, shows that ZFP36l2 is required for 
stress- induced erythroid lineage expansion in vivo. Lineage-negative (Lin-) cells 
were isolated and infected with viruses encoding GFP and either a control shRNA or 
ZFP36l2 shRNAs, and then transplanted into lethally irradiated recipient mice. 
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Figure 38. The percentages of each hematopoietic lineage cell within the GFP+ 
population. Lin- cells were isolated from E14.5 mouse fetal liver, infected with 
viruses encoding GFP and either a control shRNA or ZFP36l2 shRNAs, and 
transplanted into lethally irradiated recipient mice. 6 to 8 weeks after transplantation, 
the recipient mice were intraperitoneally injected with 60 mg/kg PHZ on day 0 and 
day 1. On day 4, spleens were dissected and measured for percentages of GFP+ cells 
of erythroid, myeloid, and B-cell lineages. P-values were calculated using the 
two-tailed t-test. a, The percentages of Ter119+ GFP+ cells are shown. b, The 
percentages of CD11b+ GFP+ cells are shown. c, The percentages of Gr-1+ GFP+ 




6-8 weeks after transplantation, PHZ or control phosphate buffered saline (PBS) was 
intraperitoneally injected into transplanted mice at days 0 and 1 to induce hemolytic 
anemia and erythroid lineage expansion. On day 4, spleens were dissected for flow 
cytometry analysis for multiple hematopoietic cells, detected by lineage specific 
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markers (Figure 35a). ZFP36l2 shRNAs effectively knocked down the expression of 
ZFP36l2 in the Lin- cells (Figure 36a), and as expected injection of PHZ resulted in a 
~10 fold increase in systemic glucocorticoid levels (Figure 35b). 
In control mice transplanted with Lin- cells infected with control shRNA, the majority 
of control transplanted GFP+ splenic cells were Ter119-negative (Ter119-) 
non-erythroid lineage cells as expected (Figures 37 and 38a). PHZ-mediated 
hemolysis induced a ~20 fold expansion of number of erythroid lineage cells (Figures 
35c) and resulted in ~50% of GFP+ cells in the spleen becoming Ter119+ mature 
erythroid cells (Figure 38a).  
Importantly, knockdown of ZFP36l2 significantly impaired this erythroid lineage 
expansion (Figures 35c). In addition, the effects of ZFP36l2 in mediating hemolysis- 
induced cell expansion is specific to the erythroid lineage, as no other hematopoietic 
lineages exhibited a difference in the number of donor- derived GFP+ cells between 
PBS and PHZ injection groups, with or without ZFP36l2 knockdown (Figure 35, d, e, 
f, and Figure 39, d, e, f). Consistent with the increase in the percentage of Ter119+ 
erythroid lineage cells of control mice upon PHZ injection, the percentages of other 
hematopoietic lineages were decreased upon PHZ injection, and these decreases were 
eliminated in the absence of ZFP36l2 (Figure 38, a, b, c ,d, and Figure 39, a, b, c).   
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Figure 39. The percentages and normalized cell numbers of GFP+ cells of T-cell 
lineages in the recipient mice. Lin- cells were isolated from E14.5 mouse fetal liver, 
infected with viruses encoding GFP and either a control shRNA or ZFP36l2 shRNAs, 
and transplanted into lethally irradiated recipient mice. 6 to 8 weeks after 
transplantation, the recipient mice were intraperitoneally injected with 60 mg/kg PHZ 
on day 0 and day 1. On day 4, spleens were dissected and measured for percentages 
and numbers of GFP+ cells of T-cell lineages. The normalized numbers of GFP+ 
T-cell lineages were calculated as a ratio of the numbers of GFP+ T-cell lineages 
relative to the percentage of GFP+ Lin- cells before transplantation. P-values were 
calculated using the two-tailed t-test. a, The percentages of CD4+ GFP+ cells are 
shown. b, The percentages of CD8+ GFP+ cells are shown. c, The percentages of 
CD4+ CD8+ GFP+ cells are shown. d, The normalized number of CD4+ GFP+ cells 
are shown. e, The normalized number of CD8+ GFP+ cells are shown. f, The 
normalized number of CD4+ CD8+ GFP+ cells are shown
53
.  
ZFP36l2 homozygous knockout mice die from HSC failure within two weeks after 
birth
58
, and thus this protein is likely required in early hematopoietic stem and 
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progenitor cells. Consistent with this notion, before PHZ challenge the percentage of 
GFP+ splenic cells is lower in mice transplanted with Lin- cells infected with viruses 
encoding either ZFP36l2 shRNA than with the control shRNA; this difference is not 
caused by significant differences in the efficiency of infection of the Lin- cells before 
transplantation (Figure 36, b, c).  
Importantly, in mice transplanted with Lin- cells expressing the control shRNA the 
percentage of GFP+ cells in the spleen does not significantly change after PHZ 
treatment, while in mice in mice transplanted with Lin- cells infected with viruses 
encoding ZFP36l2 shRNAs the percentage markedly drops following PHZ treatment 
(Figure 36d), consistent with the loss of erythroid cell expansion (Figure 
35c).Together, these data suggest that ZFP36l2 is specifically required for erythroid 
expansion during stress erythropoiesis in vivo and is consistent with the notion that it 
is essential for glucocorticoid-induced BFU-E self-renewal.  
6.1.4 ZFP36l2 delays erythroid differentiation and preferentially binds to several 
mRNAs that are induced or maintained at higher expression levels during 
terminal erythroid differentiation. 
The data in Figure 40 shows that ZFP36l2 contributes to BFU-E self-renewal by 
repressing expression of genes important for terminal erythroid differentiation. 
BFU-Es were cultured in self-renewal medium with or without DEX. At day 4, 
approximately 12% of the cells generated from BFU-Es cultured with DEX  
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Figure 40. ZFP36l2 delays erythroid differentiation and preferentially binds to 
several mRNAs that are induced or maintained at higher expression levels 
during terminal erythroid differentiation. a, BFU-Es were infected with viruses 
encoding the indicated shRNAs and cultured for 4 days in self-renewal medium with 
or without DEX. The fraction of Ter119+ cells was measured throughout all of the 
cultures. The normalized fraction of Ter119+ cells was calculated as a ratio of the 
fraction of Ter119+ cells in cultures of BFU-Es infected with viruses encoding the 
indicated shRNAs and cultured under the indicated culture conditions relative to the 
fraction of Ter119+ cells in cultures of BFU-Es infected with control virus and 
cultured with DEX. Error bar represents SD of 3 biological repeats. P-values were 
calculated using the two-tailed t-test. b, BFU-Es were infected with viruses encoding 
indicated the shRNAs and cultured for 3 days in self-renewal medium with or without 
DEX. Microarrays were carried out to profile genomic level expression patterns of 
these cells. On the x axis is the relative expression of each gene calculated as a log2 
ratio of its expression in the indicated samples. The cumulative fraction (y axis) is 
plotted as a function of the relative expression (x axis). ‘All genes’ includes all of the 
genes in the microarray; ‘Induced genes’ represent a group of 340 genes most highly 
induced during erythroid differentiation from the CFU-E stage to the Ter119+ 
erythroblast stage. P-values were calculated using the Kolmogorov-Smirnov test. c, 
BFU-Es were infected with viruses encoding indicated shRNAs and cultured for 3 
days in self-renewal medium with or without DEX. Microarrays were carried out to 
profile genomic level expression patterns of these cells. Genes that are downregulated 
by at least 20% in the presence of DEX and the subset of these genes that are 
upregulated by at least 20% upon knockdown of ZFP36l2 are shown. d, On the x axis 
is the relative expression of each gene calculated as a log2 ratio of its expression in 
CFU-Es relative to BFU-Es. The cumulative fraction (y axis) is plotted as a function 
of the relative expression (x axis). ‘Targets’ are the 2000 microarray probes 
corresponding to mRNAs that most preferentially are found in the ZFP36l2 
immunoprecipitate. ‘Non-targets’ represent all of the remaining genes. P-value was 
calculated using the Kolmogorov-Smirnov test
53
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differentiated into Ter119+ cells, whereas ~35% of the progeny of BFU-Es cultured 
without DEX became Ter119+, consistent with a DEX- triggered delay in terminal 
erythroid differentiation. This DEX-induced differentiation delay was eliminated by 
ZFP36l2 knockdown; loss of ZFP36l2 results in formation of ~30% Ter119+ cells, 
similar to the percentage in cultures without DEX (Figures 40a) suggesting that 
ZFP36l2 is essential for the glucocorticoid-induced delay of erythroid differentiation 
from the BFU-E stage. Consistent with a differentiation delay evidenced by the 
Ter119 marker, DEX treatment globally repressed the expression of a group of genes 
most highly induced during erythroid differentiation, and knockdown of ZFP36l2 
eliminated this repression (Figure 40b). As shown in Figure 40b, the average 
expression level of all genes expressed in BFU -E cells does not change with addition 
of dexamethasone, as shown by the black curve in this cumulative distribution (CDF) 
plot; the plot is centered around a zero value on the log2 scale (log2 0 =1}, which 
means that the average level of expression did not change. Based on our 
erythropoiesis gene expression databases, we chose 340 genes that are most highly 
induced during terminal erythroid differentiation. As shown in Figure 40b, the 
expression level of this group of genes is lower in BFU-Es cultured in the presence of 
DEX than their expression level in BFU-Es cultured in the absence of DEX, as 
indicated by a left shift of the expression level of these genes (green curve) in the 
CDF plot. In addition, as shown in the two panels on the right hand side of the Figure 
40b, the expression level of these genes are higher in BFU-Es with knockdown of 
ZFP36l2, as indicated by a right shift of the expression level of these genes in the  
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Figure 41. Overexpression of ZFP36l2 delays erythroid differentiation. a, 
BFU-Es were infected with  a control virus or one encoding full- length ZFP36l2, 
and cultured in self-renewal medium with or without DEX. At day 3, the expression 
levels of ZFP36l2 were measured by Western blot. b, The relative cell numbers 
throughout this in vitro BFU-E cultures are shown. Error bar represents SD of 3 
biological repeats. c, The fraction of Ter119+ cells was measured throughout each 
culture. The normalized fractions of Ter119+ cells were calculated as a ratio of the 
fraction of Ter119+ cells in cultures of BFU-Es infected with virus encoding ZFP36l2 
or with control virus and cultured under indicated culture conditions, relative to the 
fraction of Ter119+ cells in cultures of BFU-Es infected with control virus and 
cultured without DEX. Error bar represents SD of 3 biological repeats for day 2, day 3, 
and day 4 samples and of 2 biological repeats for day 1 sample. P-values were 
calculated using the two-tailed t-test. The fractions of Ter119+ cells of the biological 
repeats on days 1 to day 4 of control BFU-Es cultured without DEX are: 0.08 and 
0.13 for day 1; 0.57, 0.32, and 0.61 for day 2; 0.48, 0.27, and 0.11 for day 3; 0.23, 
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Figure 42. ZFP36l2 antibody specificity in Western blot and 
immunoprecipitation experiments. a, Indicated constructs were transfected into 
293T cells, and cells were lysed 2 days after transfection for Western blot experiments 
using the indicated antibodies. b, XZ-ZFP36l2-GFP construct was transfected into 
293T cells. Two days after transfection, cells were lysed, and immunoprecipitations 
were performed using either control IgG or ZFP36l2 antibody with the same amount 
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CDF plot. Together, these results suggest that glucocorticoids delay induction of 
erythroid differentiation genes and that ZFP36l2 is essential for this delay.This 
conclusion is further strengthened by experiments showing that overexpression of 
ZFP36l2 in BFU-Es significantly reduces the rate of cell proliferation (Figure 41, a, b) 
but also delays erythroid differentiation. When cultured 4 days in the absence of DEX 
the fraction of differentiated Ter119+ cells was significantly lower in the 
overexpression cells than in the controls, and was similar to that from control BFU-Es 
cultured with DEX  (Figure 41,c). Although overexpression of ZFP36l2 led to a 
delay in erythroid differentiation, overexpression of ZFP36l2 in BFU-Es cultured 
without DEX was not able to rescue the self-renewal divisions, suggesting that 
ZFP36l2 contributes to BFU-E self-renewal by delaying erythroid differentiation 
(Figure 41b). 
To identity mRNAs in BFU-Es that directly bind to ZFP36l2, we performed an 
RNA-binding protein immunoprecipitation, using a verified ZFP36l2 – specific 
antibody (Figure 42, a, b), coupled to a microarray (RIP-chip) assay and identified 
many genes that were specifically immunoprecipitated by the ZFP36l2 antibody. 
Using this unbiased genomic approach, we showed that mRNAs containing AU-rich 
elements in their 3’UTRs are preferentially incorporated into the antiZFP36l2 
immunoprecipitate (Figure 43); indeed ~72% of these mRNAs contain the core 
ZFP36l2 recognition motif ATTTA element in their 3’UTRs. This is consistent  
 




Figure 43. Transcripts containing AU-rich elements in their 3’UTRs are 
preferentially incorporated into the anti-ZFP36l2 immunoprecipitate. ZFP36l2 
RIP-chip was performed on freshly isolated BFU-Es. The 2000 microarray probes 
corresponding to the mRNAs that most preferentially are found in the ZFP36l2 
immunoprecipitate are grouped as ‘Targets’.  The 2000 microarray probes 
corresponding to the mRNAs that most preferentially are found in the control IgG 
immunoprecipitate are grouped as ‘Non-targets’. The percentages of targets and 
non-targets containing indicated AU-rich sequences in their 3’UTRs are shown53.  
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Figure 44. The relationship of RIP-chip target genes between the extent of 
enrichment of AU-rich elements in their 3’UTRs and the relative expression 
levels in CFU-Es relative to BFU-Es. The 2000 transcripts that were most 
preferentially found in the ZFP36l2 immunoprecipitate in RIP-chip experiments were 
ranked based on their relative expression levels, calculated as a ratio of their 
expression levels in CFU-Es relative to BFU-Es. These were then classified into 8 
groups each with 250 transcripts, based on their relative expression level ranking. 
One-way ANOVA analysis was performed to test the statistical significance of the 
difference among the average numbers of ATTTA elements in the 3’UTR of each gene 
in these 8 groups (p=0.0184). A test for linear trend after ANOVA (GraphPad) was also 
performed to test the statistical significance of the linear trend, specifically the 
systematic increase in the average number of ATTTA elements in the 3’UTR in each 
gene of these 8 groups as the rank of average relative expression levels of these 8 
groups increases (p=0.0219). a, The average number of ATTTA elements in the 3’UTR 
of each gene (y axis) positively correlates with the average relative expression levels of 
each group (x axis) for these 8 groups (p=0.0095 and R
2
=0.628 for Pearson correlation 
test). b, The percentage of genes with  ATTTA elements in their 3’UTRs (y axis) 
positively correlates with the average relative expression levels of each group (x axis) 
for these 8 groups (p=0.0304 and R
2
=0.469 for Pearson correlation test)
53
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with previous reports concerning the binding specificity of ZFP36l2
59,60
, but we 
cannot eliminate the possibility that some mRNAs are binding to other unknown 
proteins in complexes with ZFP36l2. Strikingly, we found that in BFU-Es ZFP36l2 
preferentially binds to mRNAs that tend to be induced or maintained at higher than 
average expression levels during subsequent erythroid differentiation to the CFU-E 
stage (Figure 40d). In addition, we found that the number of AU-rich elements of 
mRNAs bound by ZFP36l2 is positively correlated with their extent of induction 
during erythroid differentiation from the BFU-E to the CFU-E stage (Figure 44, a, b). 
Thus, the expression pattern of ZFP36l2 negatively correlates with the expression 
pattern of erythroid differentiation induced genes. 
 
Figure 45. Identification of potential ZFP36l2 functional target genes. A group of 
potential ZFP36l2 functional target genes was identified by intersecting RIP-chip 




To globally identify functional targets whose expression levels are regulated by 
ZFP36l2, we analyzed by microarrays the gene expression profile on day 3 of in vitro 
cultured BFU-Es, allowing us to identify several genes with lower  
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Table 2. ZFP36l2 targets several genes important for or related to erythropoiesis 




Columns 3 - 5 The expression levels of these genes at day 3 of culture of BFU-Ea 
were measured by microarray and/or RT-PCR. Column 3 The ratio of gene 
expression in BFU-Es infected with control shRNA cultured with DEX (Control 
(DEX+)) relative to its expression in BFU-Es infected with control shRNA cultured 
without DEX (Control (DEX-)). Column 4 and 5 The ratios of its expression in 
BFU-Es infected with ZFP36l2 shRNAs cultured with DEX (shRNAs(DEX+)) 
relative to its expression in BFU-Es infected with control shRNA cultured with DEX 
(Control(DEX+)). The p-value of RT-PCR experimental results of 3 biological 
repeats are shown; p-values were calculated using the two-tailed t-test; ‘***’ 
represents p<0.0001, ‘**’ represents p<0.01, and ‘*’ represents p<0.05. Column 6 
The numbers of AU-rich elements in the 3’ UTR of each gene are shown. Column 7 
The responsiveness of the 3’UTRs of selected genes were measured using luciferase 
reporter assays; the relative luciferase activities are shown. The p-value of luciferase 
reporter assays of 3 or 2 biological repeats are shown; p-values were calculated using 
the two-tailed t-test; ‘***’ represents p<0.0001, ‘**’ represents p<0.01, and ‘*’ 
represents p<0.05.  NA represents not done. 
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expression levels in BFU-Es cultured with DEX, compared with their counterparts in 
BFU-Es cultured without DEX (Figure 40c). Repression of several of these DEX 
repressed genes is dependent on and presumably mediated by ZFP36l2, since 
knockdown of ZFP36l2 eliminated this repression (Figure 40c). A group of potential 
ZFP36l2 functional target genes was then identified by intersecting the set of these 
repressed genes with the group of genes identified by RIP-chip assay (Figure 45). As 
shown in Table 2, this group of potential functional targets contains several genes 


















performed luciferase reporter assays on selected candidates, and found that the 
3’UTRs of many of these genes are ZFP36l2 responsive (Table 2). In addition, we 
mutated AU-rich elements in the 3’UTR of Aff1, and observed a statistically 
significant 21% increase (p=0.015) of luciferase activity, indicating that AU-rich 
elements are required for this regulation. 
These data illustrate that ZFP36l2 globally negatively regulates the expression of 
several erythroid differentiation - induced genes, among which some are known to be 
required for erythroid differentiation and others are unknown but induced. Regulation 
by ZFP36l2 appears similar to microRNA mediated posttranscriptional regulation. An 
individual microRNA binds to multiple target mRNAs and downregulates their 
expression levels often by only 20- 50% but collectively these modulations can have 
important biological effects. ZFP36l2 is normally downregulated during erythroid 
differentiation from the BFU-E stage, 
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Figure 46. ZFP36l2 is a “molecular switch” for glucocorticoid induced of BFU-E 
self-renewal. a, In BFU-E, upon the stimulation of glucocorticoid, GR translocates 
into nucleus and binds to enhancer region of ZFP36l2 and stimulates its expression. 
ZFP36l2 binds and negatively regulates the expression of several mRNAs that are 
induced during erythroid differentiation. b, ZFP36l2 is downregulated during 
erythroid differentiation at BFU-E stage. This downregulation favors erythroid 
differentiation. c, Under stress condition, glucocorticoid triggers the upregulation of 
ZFP36l2, which negatively regulates the expression of several genes induced during 




thus stabilizing many mRNAs required for terminal differentiation. ZFP36l2 
transcription is enhanced by glucocorticoids under stress conditions that signal 
erythroid lineage cell expansion. Upregulation of ZFP36l2 in turn negatively regulates 
multiple differentiation-induced genes, causing a delay in erythroid differentiation and 
ultimately contributing to BFU-E self-renewal (Figure 46). Thus our experiments also 
uncover a novel mechanism that facilitates progenitor self-renewal - delaying 
  75 
differentiation by posttranscriptional downregulation of expression of mRNAs critical 
for progression to the next differentiation stage. 
Stem and progenitor cell self-renewal is regulated by many extracellular proteins. 
While some signal transduction pathways, such as those induced by Notch, Wnt, and 
Hedgehog, are common to multiple stem and progenitor cells, the majority of these 
pathways are highly specific to certain cell types and physiological contexts
2,6,7,69
. 
Embryonic stem (ES) cells exemplify cell type-specific regulation, where the 
coordination of extrinsic factors including LIF and BMP, and intrinsic factors such as 
Oct4, Nanog, and Sox2, regulate different aspects of self-renewal, including the 
continuation of proliferation and the maintenance of the undifferentiated state
6,7,70
. 
Our experiments elucidate a novel type of self-renewal by post- transcriptional gene 
regulation.  
Clinically, although glucocorticoids are the first-line treatment for Diamond-Blackfan 
anemia
21
, glucocorticoid treatment causes severe side effects. Our results open a 
window towards the development of novel treatments based on a more comprehensive 
understanding of the molecular mechanisms behind the regulation of BFU-E 
self-renewal and erythrocyte production by glucocorticoids. 
6.2 Materials and methods 
6.2.1 Primary BFU-Es and CFU-Es purification, retrovirus infection and in vitro 
culture 
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Primary BFU-Es and CFU-Es were purified from mouse E14.5 fetal liver
17
. BFU-Es 
were then placed in virus solution in a 6 well plate, followed by 37°C overnight 
incubation. After incubation, virus solution was substituted by a medium 
(self-renewal medium) containing SCF (100ng/ml), EPO (2U/ml), and IGF-1 
(40ng/ml) with or without full and partial GR agonists. The cells were then in vitro 
cultured at 37°C for 9 days.  
For CFU-E differentiation assay, CFU-Es were placed in virus solution, followed by 
37°C spin infection. After infection, virus solution was substituted by an EPO 




6.2.2 Cell number counting assay and BFU-E colony formation assay 
In the BFU-E culture system, after infection with viruses encoding GFP and either 
control shRNA or ZFP36l2 shRNAs, the absolute numbers of GFP+ cells were 
counted daily by flow cytometry, where the counting beads was used as a internal 
counting standard. For BFU-E colony formation assay, after 3 days culture, GFP+ 
cells were flow cytometry sorted and cultured in methylcellulose medium (MethoCult 
SF M3436  from StemCell Technologies), and the number of BFU-E colonies 
containing a cluster of more than 20 CFU-E colonies were counted 9 days after 
culture. 
6.2.3 In vivo PHZ induced hemolytic anemia and bone marrow transplantation 
mouse model  
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Lin- cells were isolated from mouse E14.5 fetal liver and infected with viruses 
encoding GFP and either control shRNA or ZFP36l2 shRNAs and transplanted into 
lethally irradiated recipient mice. 6 to 8 weeks after transplantation, the recipient mice 
were intraperitoneally injected with 60 mg/kg PHZ or control PBS on day 0 and day 1. 
On day 4, spleens were dissected and measured for number and percentage of GFP+ 
cells and of each type of GFP+ hematopoietic lineage cell. 
6.2.4 Measurement of corticosterone level 
Mice were injected with PHZ or PBS, and plasma were prepared I hour after injection. 
Corticosterone levels were measured by using an ELISA kit according to instruction 
by the manufacturer Immunodiagnostic Systems Inc. 
6.2.5 RIP-chip and data analysis 
RIP-chip was carried out according to the instruction of EZ-Magna RIP RNA-Binding 
Protein Immunoprecipitation Kit (Millipore). BFU-Es were lysed and incubated with 
ZFP36l2 antibody (Abcam ab70775; 5ug) or control IgG (5ug) conjugated with 
magnetic beads (50ul) for 4 hours. The beads, protein, and mRNAs complexes were 
immunoprecipitated and magnetic separated. The mRNAs were purified and analyzed 
by microarray (Affymetrix mouse gene 1.0 ST array). Ratios of each microarray 
probe between its intensity in ZFP36l2 antibody immunoprecipitated sample and its 
intensity in IgG immunoprecipitated sample were calculated.  
For the AU-rich elements enrichment analysis, the 2000 microarray probes 
corresponding to the mRNAs that most preferentially bind by ZFP36l2 antibody are 
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listed as ‘Targets’.  The 2000 microarray probes corresponding to the mRNAs that 
most preferentially bind by control IgG are listed as ‘Non-targets’. The percentages of 
targets and non-targets containing indicated AU-rich element in their 3’UTR were 
calculated. 
For the cumulative distribution plot, ‘Targets’ represents the 2000 microarray probes 
corresponding to the mRNAs that most preferentially bind by ZFP36l2 antibody in 
RIP-chip experiment.  ‘Non-targets’ represents all of the rest genes. The relative 
expressions of each gene calculated as a log2 ratio between its intensity in CFU-E and 
its intensity in BFU-E
1
 were calculated (x axis). The cumulative fraction is plotted as 
a function of the relative expression (y axis). 
For the correlation analysis, the 2000 transcripts that are most preferentially found in 
the ZFP36l2 immunoprecipitate in the RIP-chip experiments were ranked based on 
their relative expression levels calculated as a ratio of their expression levels in 
CFU-Es relative to BFU-Es, and were classified into 8 groups each with 250 
transcripts based on their relative expression level ranking. One-way ANOVA 
analysis was performed to test the statistical significance of the difference among the 
average numbers of ATTTA elements in the 3’UTR of each gene of these 8 groups by 
using GraphPad software. Test for linear trend after ANOVA was performed to test the 
statistical significance of the linear trend, the systematical increase of the average 
number of ATTTA elements in the 3’UTR of each gene of these 8 groups as the rank of 
average relative expression levels of these 8 group increases, using GraphPad software. 
The average number of ATTTA elements in the 3’UTR of each gene was plotted 
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together with the average relative expression levels of each group for these 8 groups. 
The percentage of genes with ATTTA elements in their 3’UTRs was plotted together 
with the average relative expression levels of each group for these 8 groups. The linear 
trendlines were drawn and the p values and R
2 
values of the Pearson correlation test 
were calculated for these two plots. 
6.2.6 GR Chip-seq 
A total of ~7x10
7
 primary BFU-E cells were purified from mouse E14.5 fetal liver
17
. 
Cells were incubated at 37ºC for 4 hours in SFEM (Stem Span) medium containing 
SCF (100ng/ml), EPO (2U/ml), and IGF-1 (40ng/ml); followed by 1 hour stimulation 
with 100nM dexamethasone. Cells were then chemically cross-linked with 1% 
formaldehyde solution for 15 minutes at room temperature, lysed and sonicated to 
solubilize and shear cross-linked DNA in sonication buffer (50 mM HEPES pH 7.5, 
40 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 0.1% Na-deoxycholate 
and 0.1% SDS). The glucocorticoid receptor (GR) was immunoprecipitated overnight 
at 4ºC with 10µg of a combination of two antibodies bound to magnetic beads 
(Dynalbeads, Invitrogen). The antibodies used were mouse monoclonal FiGR 
(sc-12763) and MAI-510 (BuGR clone, Thermo scientific). The beads containing the 
GR bound to DNA were washed once with low salt buffer (20mM TRIS pH8, 2mM 
EDTA, 0.1% SDS, 1% Triton X100, 150mM NaCl), once with high salt buffer 
(20mM TRIS pH8, 2mM EDTA, 0.1% SDS, 1% Triton X100, 500mM NaCl), and 
once with LiCl buffer (10mM TRIS pH8, 1mM EDTA, 1% NaDOC, 1% NP40, 
150mM LiCl). Bound complexes were eluted from the beads by heating at 65ºC 
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overnight in elution buffer (50mM HEPES pH8, 10 mM EDTA, 200mM EDTA and 
1% SDS). Whole cell extract DNA was also treated for cross-link reversal and was 
used as background control. Immunoprecipitated DNA and whole cell extract DNA 
were then purified by treatment with RNAse A, proteinase K and a 
phenol:chloroform:isoamyl alcohol extraction. 
Purified DNA was prepared for sequencing according to a modified version of the 
Solexa Genomic DNA protocol. Fragmented DNA was end repaired and adapters 
were ligated. An additional gel extraction step was added to the Illumina protocol at 
this step, allowing us to collect the material between 100 and 300 bp. The purified 
DNA was subjected to 18 cycles of linker-mediated PCR as per the Illumina protocol. 
Amplified fragments between 200 and 300 bp were isolated by agarose gel 
electrophoresis and purified. High-quality samples were confirmed by the appearance 
of a smooth smear of fragments from 100 to 1000 bp, with a peak distribution 
between 150 and 300 bp. 
Sequence reads were aligned to the mouse genome (NCBI Build 37, version mm9) 
using the model-based analysis of ChIP-Seq (MACS)
72
. Sequences uniquely mapping 
to the genome with zero or one mismatch were used in further analysis. Genomic bins 
with a normalized ChIP-Seq density greater than a defined threshold were considered 
enriched or “bound,” based on a p-value of less than 10−08.  
6.2.7 Luciferase reporter assay 
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293T cells were seeded into 96 well plates 24 hours before transfection. For ZFP36l2 
enhancer experiment, 10ng luciferase reporter plasmid or control empty vector plasmid 
were co-transfected with 5ng GR into 293T cells by using Lipofectamine 2000 
transfection reagent (Invitrogen). Cells were cultured in a medium containing 1uM 
DEX and lysed 48 hours after transfection. For 3’UTR experiment, 10ng luciferase 
reporter plasmid or control vector plasmid were co-transfected with 150ng of 
XZ-ZFP36l2 into 293T cells by using Lipofectamine 2000 transfection reagent 
(Invitrogen) followed with 48 hours culture. Luciferase activities were detected by 
using a dual luciferase kit (Promega).  
6.2.8 RNA-seq, microarray, and qRT-PCR 
For RNA-seq, samples were prepared by using the RNA Sample Prep Kit (Illumina) 
and sequenced by using Illumina genome analyzer at Whitehead Institute. 
For microarray experiments, RNA was extracted by using a miRNeasy Mini kit 
(Qiagen), and microarrays were performed by using the Mouse GE 4x44k microarray 
(Agilent) at Whitehead Institute. 
For RT-PCR, RNA was extracted by using a miRNeasy Mini kit (Qiagen). Reverse 
transcription was carried out using SuperScript™ II Reverse Transcriptase 
(Invitrogen). Real-time PCR was performed by using SYBR® Green PCR Master 
Mix (Applied Biosystems) and 7500 Real-Time PCR System (Applied Biosystems). 
The following primer sequences were used for real-time PCR: ZFP36l2, forward, 
GGCCGCACAAGCACAAC, reverse, GAGACTCGAACCAAGATGAATAACG; 
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Aff1, forward, GCCTAACACTTCCTCCTGACACA, reverse, 
CTGCCTACAGCCCAAAGTCAA; Mafk, forward, GCGGCGCACACTCAAGA, 
reverse, TTTCTGTGTCACACGCTTGATG; Nef2l1, forward, 
CCCCAGAAGGCCTTTGTAACT, reverse, TCCAAGAGCATCTTCCCTTCA. 
6.2.9 Western blot 
Protein was extracted in lysis buffer (150 mM sodium chloride; 1.0% NP-40 or Triton 
X-100; 0.5% sodium deoxycholate; 0.1% SDS; 50 mM Tris, pH 8). SDS-PAGE was 
performed using the NuPAGE® Novex® Bis-Tris Gel Systems (Invitrogen). After 
electrophoretic transfer, the PVDF membranes with protein were incubated with the 
first antibody for ZFP36l2 (Abcam # ab70775; at dilution of 1:1000) or with the first 
antibody for GFP (Abcam # ab290; at dilution of 1:1000) at 4°C overnight. After 
washing and incubating with HRP conjugated secondary antibody at room 
temperature for 1 hour, membranes were developed.   
6.2.10 Immunoprecipitation experiment 
The XZ-ZFP36l2-GFP construct encoding the GFP- ZFP36l2 fusion protein was 
transfected into 293T cells. Two days after transfection, cells were lysed and 
immunoprecipitations were performed using either control IgG or ZFP36l2 antibody 
(Abcam ab70775) with the same amount of input cell lysate according to the 
instructions for the EZ-Magna RIP RNA-Binding Protein Immunoprecipitation Kit 
(Millipore). Briefly, 293T cells were lysed and incubated with control IgG (5ug) or 
ZFP36l2 antibody (Abcam ab70775; 5ug) conjugated with magnetic beads (50ul) for 
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4 hours. The beads and proteins complexes were immunoprecipitated and magnetic 
separated. The proteins were purified and analyzed by Western blot using the 
ZFP36l2 antibody (Abcam ab70775).   
6.2.11 Plasmids 
The shRNAs sequences targeting mouse ZFP36l2, c-Kit, Hopx, and Nlrp6 from Broad 
Institute RNAi consortium shRNA library were cloned into the MSCV-GFP vector.  
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shRNA2, 
aaaaCTGGATCATCATAAAGCACAAgtcgacTTGTGCTTTATGATGATCCAG. 
Sequences from mouse Aff1 3’UTR (5318bp to 6758bp) that are 1441bp in length 
containing 2 ‘ATTTA’ motifs were PCR amplified from mouse genomic DNA and 
cloned into the luciferase reporter vector psiCHECK2. Following are the primers used 
for PCR amplification: forward, GGGCTCGAGTTCTTGGTACCTTGGTTAAATC, 
reverse, GGGGCGGCCGCCCCAACTCATCTCGAATTTCAC. For mutagenesis 
experiment, the two ‘ATTTA’ motifs of Aff1 3’UTR were mutated into ‘TGGGC’. 
Sequences from mouse Mafk 3’UTR (1730bp to 2825bp) that are 1096bp in length 
containing 5 ‘ATTTA’ motifs were PCR amplified from mouse genomic DNA and 
cloned into psiCHECK2. Following are the primers for PCR amplification: forward, 
GGGGTTTAAACGAGCTCTGGGGCCACTGGAC, reverse, 
GGGGCGGCCGCCATCCCAAACAGGAAATTC. Sequences from mouse Nfe2l1 
3’UTR (3736bp to 4614bp) that are 879bp in length containing 1 ‘ATTTA’ motif were 
PCR amplified from mouse genomic DNA and cloned into psiCHECK2. Following are 
the primers for PCR amplification: forward, 
GGGGTTTAAACGCTTCCTCTGCAGGGTCTAAAC, reverse, 
GGGGCGGCCGCGTCATGTGCTCACAGCATTTC. ZFP36l2 overexpression 
construct was made by inserting ORF of ZFP36l2 into MICD4 vector. ZFP36l2 
enhancer regions (chr17:84500031-84500271; chr17:84515492-84516478; 
chr17:84518538-84519282; chr17:84585041-84585584; and 
chr17:84595103-84595494) were each PCR amplified from mouse genomic DNA and 
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cloned into the luciferase reporter vector pGL3-Basic. XZ-ZFP36l2-GFP construct was 
made by inserting ORF of ZFP36l2 without stop codon followed in frame with ORF of 
GFP into BglII and NcoI sites of XZ vector. XZ-ZFP36l2-IRES-GFP construct was 
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In mammals, terminal erythroid differentiation is a coordinated process that involves 
4 to 5 cell divisions, induction of many erythroid important genes, chromatin 
condensation and finally, enucleation, during which the condensed nucleus 
surrounded by the plasma membrane is budded off of the nascent reticulocyte
27
. EPO 
controls the first two cell divisions and several key transcription factors, including 
GATA1, control induction of genes involved in hemoglobin production and 
chromatin condensation. However, the mechanism and regulatory molecules 
underlying the final enucleation step are not well understood.  
microRNAs are a class of recently identified regulatory small RNAs that 
downregulate expression of their target genes by either mRNA degradation or 
translational inhibition
34,35,73




7.1 Results and discussion 
7.1.1 The majority of late erythroblast CFU-E abundant microRNAs are 
downregulated during terminal erythroid differentiation 
To understand quantitatively the global microRNAs expression pattern during 
terminal erythroid differentiation, we carried out RNA-seq to profile microRNA 
expression patterns of EPO-dependent CFU-E erythroid progenitors and Ter119+  
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Figure 47. microRNA expression profile as determined by RNA-seq deep 
sequencing. a, “CFU-Es” and “Ter119+” cells are high purity late erythroid 
progenitors and mature erythroblasts sorted from E14.5 mouse fetal liver (See 
Supplemental Materials for details of sorting procedures). RNA-seq deep sequencing 
specific for small RNAs was carried out for “CFU-E” and “Ter119+” cells. Data from 
the RNA-seq was normalized so that the total number of reads from “Ter119+” cells 
is equivalent to the total number of reads from “CFU-Es”. On the X-axis is RPKM 
(reads per kilobase of exon per million mapped reads) of “CFU-Es”. On the Y-axis is 
the ratio of RPKM of “Ter119+” cells relative to RPKM of “CFU-Es”. b, Twenty 
microRNAs or microRNA clusters were overexpressed in E14.5 mouse fetal Ter119- 
erythroid progenitors followed by two days in vitro culture. Day 2 cells were stained 
with Ter119-APC, CD71-PE and Hoechst. FACS analysis was carried out to 
determine the differentiation and enucleation statuses of these cells. The percentages 
of Ter119+Hochest- cells and Ter119+ cells were plotted normalized to a value of 1.0 
representing the corresponding value for control XZ vector infected cells
71
.  
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mature erythroblast cells. As shown in Figure 47a, one erythroid abundant microRNA, 
miR-451, is sharply upregulated during terminal differentiation and accounts for 12% 
of the total miRNAs at the CFU-E stage. This percentage increases to 58% at the 
Ter119+ stage. As a result of the sharp increase of miR-451 expression, the majority 
of other microRNAs are downregulated in Ter119+ cells compared with CFU-Es 
assuming the total amount of microRNA stays the same. 
Since the majority of microRNAs present in CFU-E cells are downregulated, to 
uncover the functions of these microRNAs in erythropoiesis, we carried out a 
microRNAs overexpression functional screen. Twenty abundant and developmentally 
downregulated microRNAs or microRNA clusters were cloned into the retrovirus 
vector XZ-IRES-GFP. Retroviral vectors for these microRNAs or microRNA clusters 
were transduced into mouse E14.5 fetal liver erythroid progenitors and cultured in 
vitro for 2 days to allow terminal erythroid cell proliferation and differentiation
22
. To 
determine the differentiation and enucleation statuses of microRNAs-infected cells, 
day 2 cultured cells were labeled for the erythroid lineage specific membrane protein 
Ter119, the transferrin receptor CD71, and the cell permeable DNA dye Hoechst 
33342, followed by FACS analysis. As shown previously, the cells first display 




), then induction of Ter119 and 




) during two days in vitro culture. This 





 population represents enucleated reticulocytes
61
. As shown in 
Figure 47b, overexpression of the majority of these microRNAs had no or subtle 
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effects on terminal erythroid differentiation or enucleation. Among the microRNAs 
we tested, overexpression of the miR-191-425 cluster, miR-1981 and the 
miR-181a-1-181b-1 cluster inhibited enucleation, whereas overexpression of the 
miR-27a-23a cluster promoted enucleation. Since miR-191 is the most abundant 
microRNA among these microRNAs tested, we chose the miR-191-425 cluster for 
further analysis. 
7.1.2 miR-191 modulates erythroblast enucleation 
Further analysis showed that miR-191 but not miR-425 (not shown) mediated the 
miR-191-425 overexpression phenotype. According to our RNA-seq data, miR-191 is 
an abundant microRNA that accounts for 3.5% of all microRNAs present in CFU-Es, 
while the most abundant microRNA, miR-451, accounts for 12.7%. As shown in 
Figure 47, miR-191 is downregulated ~ 6 fold from the CFU-E to the Ter119+ stage.  
E14.5 fetal livers contain at least five distinct populations of cells, R1 to R5, which 
are defined by their characteristic Ter119 and CD71 double staining patterns. CFU-E 
cells and proerythroblasts make up the R1 population; R2 consists of proerythroblasts 
and early basophilic erythroblasts; R3 includes early and late basophilic erythroblasts; 
R4 is mostly chromatophilic and orthochromatophilic erythroblasts; and R5 is 
comprised of late orthochromatophilic erythroblasts and reticulocytes
51
. As shown in 
Figure 48a, miR-191 is downregulated around 5 fold from the R1 stage to the R3 
stage.  




Figure 48. miR-191 regulates cultured mouse fetal erythroblast enucleation. a, 
miR-191 expression levels from R1 to R5 as determined by qRT-PCR; b, miR-191 
overexpression level at day 2 of in vitro cultured erythroid progenitor as determined 
by qRT-PCR; a and b U6 was the loading control. Error bar is standard deviation (SD) 
(n=3); c, Mouse fetal erythroid progenitors were infected with indicated viruses. 12 
hours after infection, GFP+ cells were sorted and cultured for another 36 hours. 
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Numbers of GFP+ cells at 12 hours and 48 hours were determined by a cell counting 
machine (BD). The normalized ratios of cell numbers at 48 hours relative to 12 hours 
were plotted. Error bar is SD (n=3); d, May-Grunwald Giemsa staining carried out on 
day 2 cultured cells infected with indicated viruses; representative images are shown 
(n=3). Arrows indicate reticulocytes; e, Day 2 in vitro cultured cells as in d stained 
with Ter119-APC, CD71-PE and Hoechst. Representative FACS plots are shown 
(n=3); f, Day 2 in vitro cultured cells as in e stained with DAPI and nucleus sizes 
were quantified by image processing. Stars (ӿӿӿ) designate p<0.001 in student t-test; 
g, qRT-PCR performed on day 2 cultured cells infected with indicated viruses. Error 
bar is SD (n=3)
71
; h, Nucleus sizes in panel f are re-plotted as a cumulative fraction 
plot. P-value of Kolmogorov-Smirnov Test is shown 
As shown in Figure 48b, using our retrovirus vector, miR-191 was overexpressed to a 
level tenfold higher than control R1 stage cells. Overexpression of miR-191 
significantly impaired enucleation; about 19% reticulocytes were detected at day 2, 
while cells infected by the empty vector XZ or by a vector encoding a control 
microRNA, miR-181d, generated almost twice that number, 34%, of reticulocytes 
(Figure 48e). The blockage of enucleation was further supported by May-Grunwald 
Giemsa staining which clearly showed that miR-191 overexpression decreased the 
percentage of enucleated cells (Figure 48d). However, miR-191 overexpression did 
not affect the induction of Ter119, suggesting that overexpression of miR-191 had no 
influence on differentiation (Figure 48e). In the Ter119-APC/Hoechst FACS plot and 
Ter119
negative
 in theTer119-APC/CD71-PE FACS plot (Figure 48e), the slight increase 
of the Ter119+ percentage in the miR-191 overexpression sample is due to the 





. Supporting this contention, Figure 48g shows that miR-191 
overexpression had no effect on the expression levels of several erythroid important 
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genes tested, including Alas2, Fech1 and Mfrn and Hbb-b1 (β globin). 
Overexpression of miR-191 slightly enhanced the rate of cell division (Figure 48c). 
The blockage of enucleation might due to the direct defects on cytokinesis
27
 or on the 
preceding event, chromatin condensation. To determine whether chromatin 
condensation was impaired by miR-191 overexpression, we carried out a single cell 
nucleus size quantification assay. As shown in Figure 48f, overexpression of miR-191 
significantly blocked chromatin condensation. Furthermore, as indicated  
 
Figure 49. Further downregulation of miR-191 has no influence on terminal 
erythroid differentiation. a, miR-191 knockdown level at day 2 of in vitro cultured 
erythroid progenitor as determined by qRT-PCR. U6 was loading control. Error bar is 
standard deviation (n=3); b, Ter119-negative mouse fetal erythroid progenitors were 
infected with miR-191 sponge or control sponge viruses. 12 hours after infection, 
GFP+ cells were sorted and cultured for another 36 hours. Numbers of GFP+ cells at 
12 hours and 48 hours were determined by a cell counting machine (BD). The 
normalized ratios of cell numbers at 48 hours relative to 12 hours were plotted. Error 
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bar is standard deviation (n=3); c, May-Grunwald Giemsa staining carried out on day 
2 cultured cells; representative images are shown (n=3). Arrows indicate reticulocytes; 
d, Day 2 in vitro cultured cells stained with APC-conjugated Ter119, PE-conjugated 
CD71 and Hoechst. FACS analysis was used to determine Ter119, CD71 expression 





Figure 50. Riok3 and Mxi1 are direct target genes of miR-191. a, Mouse Riok3 and 
Mxi1 3’UTRs contain miR-191 binding sites; mutations introduced into the target 
sequences are shown; b, Luciferase reporters together with microRNA mimics were 
cotransfected into 293T cells. The relative firefly/Renilla luciferase activity ratios 
were determined 48hours after transfection. Error bar is SD (n=3); c, qRT-PCR shows 
expression levels of Riok3 mRNA at day 2 of in vitro cultured erythroid progenitors 
following infection of indicated viruses. Error bar is SD (n=3); d, Western blot shows 
Riok3 protein levels at day 2 of in vitro cultured erythroid progenitors following 
infection of indicated viruses. Numbers below RIOK3 bands are the relative 
RIOK3/DAPDH band intensity ratios. Representative data are shown (n=3); e, 
qRT-PCR shows Mxi1 expression levels at day 2 of in vitro cultured erythroid 
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progenitors following infection of indicated viruses. Error bar is SD (n=3). Stars (ӿ) 




by the differences in the FACS forward scatter (FSC) parameters, overexpression of 
miR-191 inhibited the normal decrease in cell volume late in differentiation, 
consistent with a defect in chromatin/nuclear condensation (Figure 48e). 
The above results suggest that ectopic expression of miR-191 at a physiological level 
significantly inhibited chromatin condensation and enucleation; in other words 
prevention of the normal downregulation of miR-191 prevented chromatin 
condensation and enucleation. Since miR-191 is sharply downregulated ~ 6 fold from 
the CFU-E to the Ter119+ stage, further downregulation of miR-191 by 
loss-of-function approaches would likely not generate any obvious morphological 
phenotype. To test this hypothesis, we carried out a microRNA sponge - mediated 
miR-191 knockdown experiment
74
. miR-191 was successfully knocked down by the 
miR-191-sponge as shown by qRT-PCR (Figure 49a). Compared with a control sponge, 
only around 18% of miR-191 was detected at day 2 of in vitro cultured erythroid cells 
following miR-191-sponge infection. No obvious differentiation, enucleation or 
proliferation defects were observed (Figure 49b to d). 
7.1.3 Two developmentally upregulated and erythroid enriched genes, Riok3 and 
Mxi1, are direct targets of miR-191 
To further understand how miR-191 modulates erythroblast enucleation, we used three 
criteria to pick potential miR-191 target genes: those predicted as miR-191 target genes 
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by Targetscan, those developmentally upregulated during terminal erythroid 
differentiation according to our mRNA RNA-seq data (unpublished) and those 
 
Figure 51. Riok3 and Mxi1 are enriched in human CD71+ early erythroid cells
53
. 
a, The expression pattern of Riok3 in different tissues and cell types; b, The 




downregulated upon miR-191 overexpression in our in vitro erythroid progenitor 
culture system. Among all the genes tested, Riok3 and Mxi1 fulfilled all three criteria 
(Figure 50). 
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As shown in Figure 50a, both mouse Riok3 and Mxi1 3’UTRs contain predicted 
miR-191 binding sites. To test whether these sites are under the regulation of  
 
Figure 52. RIOK3 is required for erythroblast enucleation. a, Riok3 mRNA 
expression levels from R1 to R5 as determined by qRT-PCR. 18s rRNA was the 
loading control; b, Riok3 expression levels of in vitro cultured erythroid progenitors 
as determined by qRT-PCR. 18s was the loading control. Error bar is SD (n=3); c, 
RIOK3 protein expression levels of in vitro cultured erythroid progenitors as 
determined by Western Blot. Representative data are shown (n=3); d, Riok3 mRNA 
levels at day 2 of culture following addition of shRNAs as determined by qRT-PCR. 
18s rRNA was the loading control. Error bar is SD (n=3); e, Riok3 protein levels at 
day 2 determined by Western Blot following addition of shRNAs. Representative data 
are shown (n=3); f, Similar with Figure 48c, for samples with infection of indicated 
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viruses, the normalized ratios of cell numbers at 48 hours relative to 12 hours were 
plotted. Error bar is SD (n=3); g, May-Grunwald Giemsa staining carried out on day 2 
cultured cells infected with indicated viruses; representative images are shown (n=3). 
Arrows indicate reticulocytes; (h) Day 2 in vitro cultured cells as in g stained with 
Ter119-APC, CD71-PE and Hoechst. Representative FACS plots are shown (n=3); I, 
Day 2 in vitro cultured cells as in h stained with DAPI and nucleus sizes were 
quantified by image processing. Stars (ӿӿӿ) designate p<0.001 in student t-test; J, 





miR-191, we performed luciferase reporter assays. Sequences from Riok3 and Mxi1 
3’UTR that are ~ 500bp in length and contain the miR-191 binding sites were cloned 
into the luciferase reporter vector psiCHECK2. miR-191 mimic or negative control 
mimic were co-transfected with luciferase reporters or control empty vectors into 293T 
cells. And cells were lysed 48 hours after transfection. As shown in Figure 50b, 
luciferase activities of reporters containing Riok3 or Mxi1 3’UTR sequences were 
significantly lower than control empty vector, when co-transfected with miR-191 
mimic but not with a negative control mimic. To further prove it was the miR-191 
binding sites that mediated this regulation, three point mutations at miR-191 binding 
site were introduced into the luciferase reporters (Figure 50a). As shown in Figure 50b, 
the mutations significantly weakened the response of reporters to miR-191 mimic but 
not to the control mimic. 
To test whether Riok3 and Mxi1 are under the control of miR-191 during terminal 
erythroid differentiation, we measured Riok3 and Mxi1 expression levels in our day 2 in 
vitro cultured erythroid cells. As shown in Figures 50c to e, overexpression of miR-191 
downregulated the expression of Riok3 and Mxi1. Collectively, these results suggest 
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that Riok3 and Mxi1 are miR-191 target genes. Since little is known about the function 
of Riok3 and Mxi1 in erythropoiesis, we decided to continue our research to uncover the 
possible roles of these two genes in erythropoiesis. 
7.1.4 RIOK3 is required for erythroblast enucleation 
RIOK3 belongs to the RIO family of atypical protein kinases
75
. As shown in Figure 
51a, Riok3 is enriched in the erythroid lineage compared with other tissues and cell 
types
76
. During terminal erythroid differentiation, Riok3 is continuously upregulated 
from the R1 to R5 stage (Figure 52a) and, in our in vitro erythroid progenitor culture 
system, Riok3 showed a similar expression pattern (Figure 52b and c).  
To uncover Riok3’s function in erythropoiesis, two Riok3 specific shRNAs and a 
control Luc shRNA were introduced by retroviral infection into mouse E14.5 fetal liver 
erythroid progenitors followed by two days of in vitro culture. As shown in Figures 52d 
and e, two different and nonoverlapping Riok3 shRNAs, but not a control Luc shRNA, 
blocked Riok3 expression at both the mRNA and protein levels. Strikingly, knockdown 
of Riok3 almost completely blocked enucleation (Figure 52h). May-Grunwald Giemsa 
staining further supported the blockage of enucleation as almost no enucleated cells 
could be found in the Riok3 shRNA infected sample (Figure 52g). As shown in Figure 
52h, Riok3 shRNA infection didn’t influence the induction of Ter119 which suggested 
that knockdown of Riok3 had little if any influence on differentiation. This contention 
was further supported by qRT-PCR assay showing that knockdown of Riok3 had no 
effects on Hbb-b1 (β globin) expression and only slightly inhibited the expression of 
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the erythroid important genes tested, including Alas2, Fech1 and Mfrn (Figure 52j). 
Knockdown of Riok3 also had no influence on the cell division rate (Figure 52f) and 
by measuring the size of individual nuclei. We found that knockdown of Riok3 
severely blocked chromatin condensation (Figure 52i). This is consistent with a 
blockage of the normal decrease in cell volume, as indicated by the difference in the 
FSC parameter (Figure 52h). Collectively, these results suggested that normal 
upregulation of Riok3 is required for chromatin condensation and enucleation, and 
that its downregulation by ectopic expression of miR-191 is one reason why 
chromatin condensation and enucleation are blocked. 
7.1.5 MXI1 is required for erythroblast enucleation 
Mxi1 is a well-known c-Myc antagonist
77
. Similar to Riok3, Mxi1 is enriched in the 
erythroid lineage (Figure 51b)
76
. As shown in Figure 29A, Mxi1 is upregulated from the 
R1 to the R5 stage during terminal erythroid differentiation (Figure 53a) and this 
expression pattern was recapitulated in our in vitro erythroid progenitor culture system 
(Figure 53b).  
To uncover Mxi1’s function in erythropoiesis, shRNAs targeting Mxi1 and a control 
Luc shRNA were introduced by retroviral infection into mouse E14.5 fetal liver 
erythroid progenitors followed by two days in vitro culture. Two different and 
nonoverlapping Mxi1 shRNAs, but not a control Luc shRNA, blocked Mxi1 expression 
(Figure 53c). As shown in Figure 53F, knockdown of Mxi1 almost completely blocked 
enucleation. This was further supported by May-Grunwald Giemsa staining which 
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Figure 53. MXI1 is required for erythroblast enucleation. a, Mxi1 mRNA 
expression levels from R1 to R5 as determined by qRT-PCR. 18s rRNA was the 
loading control; b, Mxi1 expression levels of in vitro cultured erythroid progenitors as 
determined by qRT-PCR. 18s was the loading control. Error bar is SD (n=3); c, Mxi1 
mRNA levels at day 2 of culture following addition of shRNAs determined by 
qRT-PCR. 18s rRNA was the loading control. Error bar is SD (n=3); d, Similar with 
Figure 48c, for samples with infection of indicated viruses, the normalized ratios of 
cell numbers at 48 hours relative to 12 hours were plotted. Error bar is SD (n=3); e, 
May-Grunwald Giemsa staining carried out on day 2 cultured cells infected with 
indicated viruses; representative images are shown (n=3). Arrows indicate 
reticulocytes; f, Day 2 in vitro cultured cells as in e stained with Ter119-APC, 
CD71-PE and Hoechst. Representative FACS plots are shown (n=3); g, Day 2 in vitro 
cultured cells as in f stained with DAPI and nucleus sizes were quantified by image 
processing. Stars (ӿӿӿ) designate p<0.001 in student t-test; h, qRT-PCR performed on 
day 2 cultured cells infected with indicated viruses. Error bar is SD (n=3)
71
.  
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showed that almost no enucleated cells could be detected (Figure 53e). As shown in 
Figure 53F, Mxi1 shRNA infection didn’t influence the induction of Ter119, 
suggesting that knockdown of Mxi1 had no influence on differentiation. This is 
further supported by the qRT-PCR assay shown in Figure 53H: knockdown of Mxi1 
had no effect on Hbb-b1 (β globin) expression and only slightly inhibited the 
expression of the erythroid important genes tested, including Alas2, Fech1 and Mfrn. 
In addition, knockdown of Mxi1 slightly increased the rate of cell division (Figure 
53d). Importantly, knockdown of Mxi1 severely blocked chromatin condensation 
(Figure 53g), and concomitantly blocked the normal decrease in cell volume (Figure 
53f). These results suggest that normal upregulation of Mxi1 is required for chromatin 
condensation and enucleation. 
7.1.6 Knockdown of Riok3 or Mxi1 or overexpression of miR-191 blocked Gcn5 
downregulation 
Erythroblast enucleation occurs only in terminal mammalian erythroblasts: late 
erythroblasts extrude their condensed nuclei surrounded by a plasma membrane, 
forming enucleated reticulocytes. Several cytoskeletal components are involved in 
enucleation
78
. Preceding enucleation is chromatin condensation, which is 
accompanied by histone modifications
79
. Additionally, the requirement for histone 
deacetylases (HDACs) in erythroblast chromatin condensation was suggested by the 
observation that treatment with a pan- HDAC inhibitor blocked erythroblast 
chromatin condensation and enucleation
80
. This group, using Friend virus-infected 
erythroblast as a model system, further suggested that HDAC5 is upregulated during 
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the terminal differentiation stages of erythroblast differentiation and that expression of 
HDAC5 is correlated with chromatin condensation. In contrast, using our primary 
erythroid progenitor in vitro culture system and an shRNA based knockdown 
approach, we showed that HDAC2, but not HDAC5, is required for chromatin 
condensation and enucleation
30
. Additionally, c-Myc is strongly downregulated 
during terminal erythroid differentiation and ectopic expression of c-Myc blocks the 
downregulation of the histone acetyltransferase (HAT), GCN5. Ectopic expression 
either of c-Myc or GCN5 blocks chromatin condensation and enucleation
81
. Histone 
deactylation is correlated with terminal erythroid chromatin condensation but much 
remains to be learned about the mechanisms and proteins used in erythroid cells to 
condense their nucleus. 
Since MXI1 is a well known c-Myc antagonist
77
, it is possible that the upregulation of 
MXI1 during terminal erythroid differentiation is required for the down-modulation of 
c-Myc activity, the downregulation of Gcn5 expression and proper chromatin 
condensation and enucleation. As shown in Figure 54a, in our in vitro culture system, 
Gcn5 expression normally is downregulated ~ 5 fold at day 2 compared with day 0. 
Importantly, we found that knockdown of either MXI1 or RIOK3 blocked GCN5 
downregulation, as did overexpression of miR-191 (Figure 54b). At day 2 of our in 
vitro cultures, the Gcn5 expression level in either MXI1 or RIOK3 knockdown cells is 
~2 fold that of control cells, which is comparable to the reported expression level of 
ectopic Gcn5
81
 that blocks chromatin condensation and enucleation. These data 
suggest that blockage of Gcn5 downregulation is at least part of the molecular 
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explanation of how MXI1 and RIOK3 are required for normal chromatin 
condensation and enucleation. In addition, we found that overexpression of miR-191 
also blocked Gcn5 downregulation (Figure 54b) which further supports the notion that 
Riok3 and Mxi1 are target genes of miR-191. 
 
Figure 54. Knockdown of Riok3 or Mxi1 or overexpression of miR-191 blocks 
Gcn5 downregulation. a, Gcn5 expression levels of in vitro cultured erythroid 
progenitors as determined by qRT-PCR. 18s RNA was the loading control; b, Gcn5 
mRNA levels at day 2 of culture, determined by qRT-PCR, following addition of 
RIOK3 or MXI1 shRNAs or overexpression of miR-191. 18s RNA was the loading 




According to our RNA-seq data, there are in addition to miR-191 many other 
microRNAs that are also abundant in CFU-E progenitors and developmentally 
downregulated during terminal erythroid differentiation. In our microRNA functional 
screen, we found that ectopic expression of the majority of microRNAs tested had 
subtle or no effect on erythroid differentiation or enucleation. However, our functional 
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screen may underestimate the complexity of these biological systems as well as the 
important roles that microRNAs play as gene expression modulators, such as buffering 
environment perturbations and maintaining the robustness of biological systems
82
. One 
such important lesson comes from recent research focusing on miR-451’s function in 
erythropoiesis: miR-451 is strongly upregulated during terminal erythroid 
differentiation and is dispensable for erythropoiesis under normal conditions. However, 
mice lacking miR-451 display a reduction in hematocrit, an erythroid differentiation 
defect, and ineffective erythropoiesis in response to oxidative stress
42–44
. Hence, it is 
possible that other microRNAs without obvious phenotypes in our screen may indeed 
be important for regulating cellular functions such as responses to stress or other 
environmental perturbations not analyzed in our developmental screen. 
Despite the fact that mammalian Riok3 was originally cloned as the homolog of the 
Aspergillus nidulans sudD gene more than 10 years ago
83
, the biological function of 
Riok3 is largely uncharacterized. Here we showed that Riok3 is upregulated during 
terminal erythroid differentiation, and that knockdown of Riok3 blocked chromatin 
condensation and enucleation. Our data further suggests that RIOK3 may be involved 
in regulating Gcn5 expression. MXI1 is a well known c-Myc activities antagonist. 
Our data suggested that MXI1, c-Myc and GCN5 may form a cascade regulating 
histone deacetylation and chromatin condensation during terminal erythroid 
differentiation. 
Altogether our results illustrate and extend on the increasing evidence that 
microRNAs play important and necessary role in erythropoiesis and how the quieting 
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of a specific microRNA may be crucial at a very specific critical stage of erythroid 
development. 
7.2 Materials and methods 
7.2.1 RNA-seq 
To obtain high purity “CFU-Es”, homogenized mouse E14.5 fetal liver cells were 
negatively selected by depleting Ter119, B220, Mac-1, CD3 and Gr-1 positive cells. 
The remaining fraction was further sorted to obtain the C-kit positive and CD71 high 
population
17. “Ter119+” cells are C-kit negative and Ter119 positive mature 
erythroblasts.  
For RNA-seq, samples prepared were prepared by using the Small RNA Sample Prep 
Kit (Illumina) and sequenced by using Illumina genome analyzer at Whitehead 
Institute. 
7.2.2 Plasmids 
microRNAs or microRNA clusters and ~ 250bp flanking sequences on both 5’ and 3’ 
sides were PCR amplified from mouse genomic DNA and cloned into the 
XZ-IRES-GFP vector. Sequences from Riok3 and Mxi1 3’UTR that are ~ 500bp in 
length and contain the miR-191 binding sites were PCR amplified from mouse genomic 
DNA and cloned into the luciferase reporter vector psiCHECK2. Following are the 
primers used for PCR amplification: Mxi1, forward, 
GGGCTCGAGTTCAAGCATCACAAAGATGTCC, reverse, 
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GGGGCGGCCGCTGGGATGGTAAAAGGGAAAG; Riok3, forward, 
GGGCTCGAGTGGTACACCGTAGATGTGTGG, reverse, 
GGGGCGGCCGCGGGGTAATGAGGTGAGAGCA. Three point mutations at the 
miR-191 binding site were introduced into the Riok3 and Mxi1 luciferase reporters 
using Stratagene's QuikChange II Site Directed Mutagenesis Kit (Biocompare). 
Following are the primers used for introducing the point mutations: Mxi1 mutation, 
forward, CCTGACAAAGTTATTTTAATGCAGGTCTGGTTAGCAGAGGTAAG, 
reverse, CTTACCTCTGCTAACCAGACCTGCATTAAAATAACTTTGTCAGG; 
Riok3 mutation, forward, GGCAGTGAAACATTGCAGGTTACGTTTCCCC, reverse, 
GGGGAAACGTAACCTGCAATGTTTCACTGCC. The shRNAs sequences 
targeting mouse Riok3 and Mxi1 from Broad Institute RNAi consortium shRNA 
library (http://www.broadinstitute.org/rnai/trc/lib) were cloned into the MSCV-GFP 








7.2.3 Mouse fetal liver erythroid progenitor purification, retrovirus infection and 
in vitro culture 
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Homogenized mouse E14.5 fetal liver cells were incubated with a biotin conjugated 
antibody mixture that includes Lin- Kit (BD 559971), Ter119 (eBioscience 
13-5921-85), CD16/32 (Abcam 25249), Sca-1 (BD 553334), CD34 (MCA1825B), 
CD41 (MCA2245B) and then incubated with Streptavidin Particles (BD 557812). 
Magnetic based negative selection was then carried out to deplete mature erythrocytes 
and differentiated non-erythroid cells
17
. 
For retrovirus infection, purified erythroid progenitors were resuspended in virus 
solution in a 6 well plate, at a density of 1 million cells per well, followed by 37°C 
spin infection for 1.5 hours. After spin infection, virus solution was substituted by 
EPO containing differentiation medium
22
. The cells were then in vitro cultured at 
37°C for two days. 
7.2.4 Flow cytometry analysis and sorting 
For flow cytometry analysis, 48 hour in vitro cultured erythroid cells were stained 
with Propidium Iodide (PI), APC-conjugated Ter119, PE-conjugated CD71 and 
Hoechst and followed by FACS analysis (BD LSR flow cytometer)
27
.    
For flow cytometry sorting of GFP+ cells, 48 hour in vitro cultured erythroid cells 
were stained with PI (1µg/ml). GFP-positive/PI-negative cells were sorted on a BD 
FACSAria Cell Sorter.  
For flow cytometry sorting of R1 to R5 stages erythroid cells, homogenized mouse 
E14.5 fetal liver cells were incubated with Biotin-Ter119 antibody. Ter119+ 




) and R5 
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(CD71
low
), based on the expression levels of CD71. The Ter119- cells were further 
incubated with an antibody mixture that includes Lin- Kit (BD 559971), CD16/32 
(Abcam 25249), Sca-1 (BD 553334), CD34 (MCA1825B), CD41 (MCA2245B) to 
deplete non-erythroid cells. The remaining cells were then further sorted into 2 
fractions, R1 (CD71
low
) and R2 (CD71
high
), based on the expression level of CD71. 
7.2.5 May-Grunwald Giemsa staining 
~ 50,000 in vitro cultured erythroid cells were centrifuged onto a slide. Then standard 
May-Grunwald Giemsa staining was carried out
22
.  
7.2.6 Cell proliferation assay 
Ter119-negative mouse fetal erythroid progenitors were mock infected or infected 
with miR-191, empty XZ vector, Riok3 shRNA, Mxi1 shRNA or Luc shRNA viruses. 
12 hours after infection, GFP+ cells were sorted and cultured for another 36 hours. 
Numbers of GFP+ cells at 12 hours and 48 hours were determined by a cell counting 
machine (BD). The normalized ratios of cell numbers at 48 hours relative to 12 hours 
were termed as proliferation ratios and plotted. 
7.2.7 Single cell nucleus size quantification 
~ 5,000 to 10,000 in vitro cultured erythroid cells were centrifuged onto a slide. After 
drying in air, the slides were covered with DAPI mounting medium (ProLong® Gold 
antifade reagent with DAPI, Invitrogen). The pictures of DAPI stained slides were 
taken under a fluorescence microscope (40 × objective; Nikon E800 upright 
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microscope). To quantify the nucleus size, 30 pictures were taken from randomly 
chosen fields for each sample. Quantification of DAPI positive areas was carried out by 
using Image J software. 
7.2.8 qRT-PCR and Western blot 
In vitro culture erythroid cells were collected using QIAzol (Qiagen). RNA including 
microRNA was extracted by using a miRNeasy Mini kit (Qiagen). For mRNA 
qRT-PCR, reverse transcription was carried out using SuperScript™ II Reverse 
Transcriptase (Invitrogen). Real-time PCR was performed by using SYBR® Green 
PCR Master Mix (Appied Biosystems) and 7500 Real-Time PCR System (Appied 
Biosystems). The PCR primers were designed by using Primer3 software 
(http://frodo.wi.mit.edu/primer3/) and the oligos were synthesized from Invitrogen. 
The following primer sequences were used for real-time PCR: 
RIOK3, forward, CCGCATGTGGGCAGAGA, reverse, 
TTCCAGCCTTCTGCATTCTTG; MXI1, forward, GCTCACCTGCGCCTGTGT, 
reverse, GGCCCAGCGGGATCA; Alas2, forward, GCATTCGCAACAGTGGTGC, 
reverse, GGCCTGGGTCATTGTGTCTG; Fech1, forward, 
GGTGGATCCCCCATCAAGAT, reverse, CACCATGCCTTCTCCTTGCT; Mfrn, 
forward, GGGTTTGGAGAGCAGCATT, reverse, 
CAGCACGACAGACATCCACAC; Hbb-b1, forward, 
CCTTTGCCAGCCTCAGTGAG, reverse, CAGGATCCACATGCAGCTTGT. 
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For microRNA qRT-PCR, reverse transcription was carried out by using a TaqMan® 
MicroRNA Reverse Transcription Kit (Appied Biosystems). The following real-time 
PCR analyses were performed using TaqMan® Universal PCR Master Mix (Appied 
Biosystems) and the 7500 Real-Time PCR System (Appied Biosystems). The 
real-time PCR probes were TaqMan® MicroRNA Assays from Appied Biosystems. 
For Western Blot, in vitro cultured erythroid cells were collected and lysed in lysis 
buffer (150 mM sodium chloride; 1.0% NP-40 or Triton X-100; 0.5% sodium 
deoxycholate; 0.1% SDS; 50 mM Tris, pH 8). SDS-PAGE was performed using the 
NuPAGE® Novex® Bis-Tris Gel Systems (Invitrogen). After electrophoretic transfer, 
the PVDF membranes with protein were incubated with the first antibody (RIOK3, 
Proteintech, 13593-1-AP; at dilution of 1:1000) overnight at 4°C followed by 
incubation with HRP conjugated secondary antibody (Jackson Immunoresearch; at 
dilution of 1:2000) for 1 hour at room temperature. The intensities of bands were 
quantified by using Image J.  
7.2.9 Luciferase reporter assay 
293T cells were seeded into 96 well plates 24 hours before transfection. 10ng luciferase 
reporter plasmid or control vector plasmid were co-transfected with 10nM miR-191 
mimic or negative control mimic (Dharmacon) into 293T cells by using Lipofectamine 
2000 transfection reagent (Invitrogen). Cells were lysed 48 hours after transfection and 
luciferase activities were detected by using a dual luciferase kit (Promega). The 3’UTR 
of firefly luciferase gene with insertion of microRNA binding site was under the 
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regulation of microRNA. The Renilla luciferase was under the control of a constitutive 
promoter and used for normalization.   
7.2.10 Student t-test 
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8. Conclusions and Future Directions 
Red blood cells account for more than 99% of total blood cells, and humans generate 
2.4 million red blood cells every second to maintain the homeostasis of this large cell 
population. It is widely known that the hormone EPO serves as the principal regulator 
of red blood cell production at the CFU-E stage, through its downstream signaling 
pathways. However, our understanding of erythropoiesis at the earlier BFU-E stage 
and the regulation of erythropoiesis by means other than protein-mediated 
mechanisms, such as non-coding RNAs, is very limited
10,16,54
. 
In the first part of my thesis, I identified the first GR target gene, the RNA binding 
protein ZFP36l2, as an essential component for BFU-E self-renewal
53
. Under stress 
conditions such as acute blood loss or chronic anemia, glucocorticoids trigger 
self-renewal of BFU-E progenitors, leading to the production of more BFU-Es, 
CFU-Es, and ultimately, mature erythrocytes.  ZFP36l2 is normally downregulated 
during erythroid differentiation from the BFU-E stage but its expression is maintained 
by all tested GR agonists that stimulate BFU-E self-renewal. In cultured BFU-Es, 
knockdown of ZFP36l2 did not affect the rate of cell division but disrupted 
glucocorticoid-induced BFU-E self-renewal, and in transplanted erythroid progenitors, 
knockdown of Zfp36l2 prevented the expansion of erythroid lineage progenitors 
normally seen after induction of anemia by phenylhydrazine treatment. I then 
demonstrated that ZFP36l2 preferentially binds to and negatively regulates expression 
levels of mRNAs that are induced or maintained at high expression levels during 
  113 
erythroid differentiation. Altogether, I found that ZFP36l2 acts as an important 
molecular switch balancing BFU-E self-renewal and differentiation. 
Although ZFP36l2 is required for BFU-E self-renewal, overexpression of ZFP36l2 
alone is not sufficient to trigger BFU-E self-renewal, suggesting that other genes 
involved in BFU-E self-renewal are yet to be identified and functionally 
characterized
17
. Moreover, self-renewal consists of both blockage of differentiation 
and continuation of proliferation
6,7,69
. However, we showed that overexpression of 
ZFP36l2 can partially mimic the glucocorticoid - induced differentiation delay
53
. We 
expect that other essential genes required for BFU-E self-renewal may either 
contribute to additional differentiation delay or continuation of proliferation.  
Therefore, to better understand the molecular network underlying BFU-E self-renewal, 
one of the most important questions for future research is to identify other novel 
molecular players in glucocorticoid-mediated BFU-E self-renewal. Previous research 
has shown that incubating BFU-Es with glucocorticoids for 4 hours triggers the 
upregulation of around 80 genes that represent potential transcriptional target genes of 
the glucocorticoid receptor. Through an extensive literature review, I found that some 
of these genes are linked to the self-renewal of hematopoietic stem and progenitor 
cells. The leukemia-associated gene Trib2 is one of these examples.  
Trib2 is one of the 80 genes that are upregulated by glucocorticoids in cultured 
BFU-Es. Previously, Trib2 has been associated with leukemic stem and progenitor 
cells: Trib2 expression is elevated in a subset of human AML patient samples, and is 
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down-regulated in leukemic cells undergoing growth arrest, suggesting that Trib2 
confers growth advantages to and enhances the self-renewal capacity of these cells
84
. 
These two clues suggest that Trib2 may contribute to glucocorticoid-triggered BFU-E 
self-renewal. To test the potential contribution of Trib2 to BFU-E self-renewal, in my 
own laboratory I will design shRNAs to abrogate Trib2 expression in BFU-Es and test 
whether Trib2 is indispensible for glucocorticoid-triggered BFU-E self-renewal, using 
experiments similar to the ones I conducted on Zfp36l2. If Trib2 is indeed required 
for BFU-E self-renewal, we will use the mice transplantation and PHZ induced stress 
erythropoiesis model to test the in vivo contribution of Trib2 to erythroid lineage 
expansion. Further analysis will focus on the underlying molecular mechanisms 
behind Trib2’s function in BFU-E self-renewal. 
In addition to Trib2, Bcl-2 is another gene that is upregulated by glucocorticoids. Bcl2 
belongs to a family of anti-apoptotic genes and its upregulation may contribute to the 
survival of BFU-Es. In fact, one of its family members, Bcl-XL, has been widely 
linked with the survival of hematopoietic cells. For example, in erythroid progenitors, 
Epo/EpoR triggers the activation JAK-STAT5 pathway which then upregulate 
Bcl-XL, and Bcl-XL contributes to survival of erythroid progenitors and increased 
production of erythrocytes. Therefore, the upregulation of Bcl-2 may also contribute 
to the survival of BFU-Es. I plan to test the contribution of Bcl-2 to BFU-Es survival 
by shRNA medicated knockdown methods. 
Another important question is to further functionally characterize Zfp36l2’s role in 
BFU-E self-renewal. Previously, it has been shown that Zfp36l2 is a component of the 
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processing body, a subcellular structure that triggers degradation of mRNAs. 
Therefore, we plan to identify interaction partners of Zfp36l2 in BFU-Es through 
co-immunoprecipitation experiments followed by mass-spectrometry analysis to 
isolate proteins that physically interact with Zfp36l2. Further experiments will focus 
on the functional analysis of the contribution of each of these components to BFU-E 
self-renewal, using experiments similar to the ones I conducted on Zfp36l2. We will 
also monitor how the processing body behaves during BFU-E cell division, whether 
there is polarized localization of the processing body during BFU-E cell division, and 
what the localization of each of these components looks like.  
Finally, this research enables us to not only understand the molecular mechanisms 
underlying glucocorticoid- triggered BFU-E self-renewal, but also to identify novel 
compounds that can substitute for glucocorticoids in the treatment of Epo-resistant 
anemias. Therefore, we are beginning to carry out a small chemical compound 
screening to identify effective novel compounds. We are starting with a chemical 
compound library of ~2200 FDA approved compounds and other novel drug- like 
compounds. We will utilize a 394 well-plate primary BFU-E culture platform, and 
culture the cells in glucocorticoid negative medium. In each well, we will put 20µM 
of each single compound, and after 9 days culture we will count the numbers of cell in 
each well. For the positive compounds, we will move to a more physiologically 
relevant in vivo pre-clinical testing and will functionally characterize how each 
compound positively regulates BFU-E self-renewal.  
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In the second part of my thesis, I identified microRNA-191 as a key regulator of 
erythroblast enucleation
71
. The majority of microRNAs present in CFU-E erythroid 
progenitors are developmentally downregulated and ectopic overexpression of 
miR-191 blocked erythroid enucleation but had only minor effects on proliferation 
and differentiation. Mechanistically, miR-191 directly targets two erythroid enriched 
and developmentally upregulated genes, Riok3 and Mxi1. Knockdown of either of 
these genes blocked enucleation and either physiological overexpression of miR-191 
or knockdown of Riok3 or Mxi1 blocked chromatin condensation. Thus, my work 
established that miR-191 downregulation, and subsequent upregulation of Riok3 and 
Mxi1, is essential for erythroid chromatin condensation and enucleation. 
Enucleation is a complex process that requires the coordination of several cellular 
activities, such as terminal differentiation, cell cycle exit, chromatin condensation, 
and cytoskeleton rearrangement
26,29,30,81,85,86
. We discovered that miR-191 is required 
for enucleation and that it contributes to enucleation regulation by allowing the 
downregulation of a histone-modifying enzyme and ultimately leading to chromatin 
condensation. These findings will guide future studies on mechanisms behind the role 
of other microRNAs required for enucleation.    
In addition to miR-191, my functional screening identified a few other downregulated 
microRNAs that could also be important inhibitors of enucleation or other stages of 
late erythroid differentiation. For each of these microRNAs, I will first use erythroid 
differentiation marker genes, such as hemoglobin, heme biosynthetic enzymes, and 
major red cell membrane and cytoskeleton proteins, to determine whether, when 
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ectopically expressed or knocked down, each microRNA contributes solely to 
enucleation or to both differentiation and enucleation. After determining this, I will 
take advantage of microRNA target prediction databases such as Targetscan to 
identify potential target genes. Concurrently, we will perform microarray experiments 
to identify genes that are differentially expressed between control samples and 
microRNA knockdown/overexpression samples. By intersecting these two gene lists, 
we will identify functional target genes that are both predicted as a microRNA target 
and are differentially expressed. Further research will focus on the functional analysis 
of these microRNA target genes and on how they regulate erythroid enucleation and 
differentiation.  
In addition to the functions of microRNAs in normal erythroid cell development, we 
are also interested in their potential contribution to the pathogenesis of blood diseases 
related to erythroid lineage cells; one of the microRNAs we are currently testing is 
miR-125b. In our primary erythroid cell culture system, miR-125b is expressed at low 
levels in erythroid cells, and overexpression of miR-125b blocks erythroid 
differentiation, resulting in larger erythroid cells. Interestingly, overexpression of this 
microRNA has also been linked to certain types of AML, and many of these patients 
also have macrocytic anemia
87
. Therefore, we hypothesize that overexpression of 
miR-125b contributes not only to the pathogenesis of AML but also to macrocytic 
anemia. We plan to perform mouse bone marrow transplantation experiments to test 
whether miR-125b alone is able to cause macrocytic anemia. Mechanistically, we 
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plan to identify target genes of miR-125b and to characterize how overexpression of 
miR-125b leads to blockage of erythroid differentiation. 
In conclusion, my thesis work uncovered two novel posttranscriptional regulatory 
mechanisms of erythropoiesis: the RNA binding protein based mechanism facilitates 
BFU-E progenitor self-renewal by delaying differentiation through posttranscriptional 
downregulation of the expression of mRNAs critical for progression to the next 
differentiation stage, and the microRNA based mechanism assists erythroblast 
enucleation by posttranscriptional downregulation of the expression of mRNAs 
important for this process. Altogether, my research highlights the importance of 
posttranscriptional regulation in erythropoiesis and opens a few novel fields in both 
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